JPS6123165B2 - - Google Patents
Info
- Publication number
- JPS6123165B2 JPS6123165B2 JP57031097A JP3109782A JPS6123165B2 JP S6123165 B2 JPS6123165 B2 JP S6123165B2 JP 57031097 A JP57031097 A JP 57031097A JP 3109782 A JP3109782 A JP 3109782A JP S6123165 B2 JPS6123165 B2 JP S6123165B2
- Authority
- JP
- Japan
- Prior art keywords
- drug
- adhesive film
- carrier
- layer
- pressure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229940079593 drug Drugs 0.000 claims description 102
- 239000003814 drug Substances 0.000 claims description 102
- 239000002313 adhesive film Substances 0.000 claims description 32
- 239000004820 Pressure-sensitive adhesive Substances 0.000 claims description 31
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 21
- 239000002861 polymer material Substances 0.000 claims description 21
- 238000004519 manufacturing process Methods 0.000 claims description 19
- 239000000758 substrate Substances 0.000 claims description 17
- 239000002131 composite material Substances 0.000 claims description 16
- 239000007787 solid Substances 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 3
- 239000012466 permeate Substances 0.000 claims description 3
- 239000012876 carrier material Substances 0.000 claims 1
- 238000005470 impregnation Methods 0.000 claims 1
- 239000010410 layer Substances 0.000 description 46
- 239000000126 substance Substances 0.000 description 20
- 229920001577 copolymer Polymers 0.000 description 17
- 239000000463 material Substances 0.000 description 17
- 239000000203 mixture Substances 0.000 description 15
- 238000000034 method Methods 0.000 description 11
- 230000001070 adhesive effect Effects 0.000 description 10
- 229920001971 elastomer Polymers 0.000 description 10
- 239000000178 monomer Substances 0.000 description 10
- 239000005060 rubber Substances 0.000 description 10
- 239000000853 adhesive Substances 0.000 description 9
- 239000012790 adhesive layer Substances 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 8
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 8
- -1 polyethylene Polymers 0.000 description 8
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 7
- 239000000006 Nitroglycerin Substances 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 229960003711 glyceryl trinitrate Drugs 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000000969 carrier Substances 0.000 description 6
- 239000004745 nonwoven fabric Substances 0.000 description 6
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 5
- 238000009792 diffusion process Methods 0.000 description 5
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 description 5
- 229960004194 lidocaine Drugs 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 229920006243 acrylic copolymer Polymers 0.000 description 4
- 230000006866 deterioration Effects 0.000 description 4
- 229960003957 dexamethasone Drugs 0.000 description 4
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 4
- 229960001347 fluocinolone acetonide Drugs 0.000 description 4
- 229960000905 indomethacin Drugs 0.000 description 4
- 229960001047 methyl salicylate Drugs 0.000 description 4
- 229920006267 polyester film Polymers 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920000297 Rayon Polymers 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 239000005038 ethylene vinyl acetate Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000000017 hydrogel Substances 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 231100000344 non-irritating Toxicity 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 3
- 239000002964 rayon Substances 0.000 description 3
- 229920003002 synthetic resin Polymers 0.000 description 3
- 239000000057 synthetic resin Substances 0.000 description 3
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 244000043261 Hevea brasiliensis Species 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- 239000004902 Softening Agent Substances 0.000 description 2
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- VIROVYVQCGLCII-UHFFFAOYSA-N amobarbital Chemical compound CC(C)CCC1(CC)C(=O)NC(=O)NC1=O VIROVYVQCGLCII-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000012752 auxiliary agent Substances 0.000 description 2
- 229940092705 beclomethasone Drugs 0.000 description 2
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 description 2
- 229960005274 benzocaine Drugs 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 239000002360 explosive Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 229920003052 natural elastomer Polymers 0.000 description 2
- 229920001194 natural rubber Polymers 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000002985 plastic film Substances 0.000 description 2
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 229920000346 polystyrene-polyisoprene block-polystyrene Polymers 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- QJBZDBLBQWFTPZ-UHFFFAOYSA-N pyrrolnitrin Chemical compound [O-][N+](=O)C1=C(Cl)C=CC=C1C1=CNC=C1Cl QJBZDBLBQWFTPZ-UHFFFAOYSA-N 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 239000004945 silicone rubber Substances 0.000 description 2
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229920001567 vinyl ester resin Polymers 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- DIWRORZWFLOCLC-HNNXBMFYSA-N (3s)-7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound N([C@H](C(NC1=CC=C(Cl)C=C11)=O)O)=C1C1=CC=CC=C1Cl DIWRORZWFLOCLC-HNNXBMFYSA-N 0.000 description 1
- OUPZKGBUJRBPGC-UHFFFAOYSA-N 1,3,5-tris(oxiran-2-ylmethyl)-1,3,5-triazinane-2,4,6-trione Chemical compound O=C1N(CC2OC2)C(=O)N(CC2OC2)C(=O)N1CC1CO1 OUPZKGBUJRBPGC-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 1
- FWWXYLGCHHIKNY-UHFFFAOYSA-N 2-ethoxyethyl prop-2-enoate Chemical compound CCOCCOC(=O)C=C FWWXYLGCHHIKNY-UHFFFAOYSA-N 0.000 description 1
- ZVYGIPWYVVJFRW-UHFFFAOYSA-N 3-methylbutyl prop-2-enoate Chemical compound CC(C)CCOC(=O)C=C ZVYGIPWYVVJFRW-UHFFFAOYSA-N 0.000 description 1
- CPHGOBGXZQKCKI-UHFFFAOYSA-N 4,5-diphenyl-1h-imidazole Chemical compound N1C=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 CPHGOBGXZQKCKI-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- WJOHZNCJWYWUJD-IUGZLZTKSA-N Fluocinonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(=O)C)[C@@]2(C)C[C@@H]1O WJOHZNCJWYWUJD-IUGZLZTKSA-N 0.000 description 1
- PLDUPXSUYLZYBN-UHFFFAOYSA-N Fluphenazine Chemical compound C1CN(CCO)CCN1CCCN1C2=CC(C(F)(F)F)=CC=C2SC2=CC=CC=C21 PLDUPXSUYLZYBN-UHFFFAOYSA-N 0.000 description 1
- AGJUUQSLGVCRQA-SWOUQTJZSA-N Fungichromin Chemical compound CCCCC[C@@H](O)[C@@H]1[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)[C@@H](O)[C@H](O)\C(C)=C\C=C\C=C\C=C\C=C\[C@H](O)[C@@H](C)OC1=O AGJUUQSLGVCRQA-SWOUQTJZSA-N 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 102000001399 Kallikrein Human genes 0.000 description 1
- 108060005987 Kallikrein Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- NPPQSCRMBWNHMW-UHFFFAOYSA-N Meprobamate Chemical compound NC(=O)OCC(C)(CCC)COC(N)=O NPPQSCRMBWNHMW-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- MKPDWECBUAZOHP-AFYJWTTESA-N Paramethasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]2(C)C[C@@H]1O MKPDWECBUAZOHP-AFYJWTTESA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- AGJUUQSLGVCRQA-UHFFFAOYSA-N Pentamycin Natural products CCCCCC(O)C1C(O)CC(O)CC(O)CC(O)CC(O)CC(O)C(O)C(O)C(C)=CC=CC=CC=CC=CC(O)C(C)OC1=O AGJUUQSLGVCRQA-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- MJNIWUJSIGSWKK-BBANNHEPSA-N Riboflavin butyrate Chemical compound CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)CN1C2=CC(C)=C(C)C=C2N=C2C1=NC(=O)NC2=O MJNIWUJSIGSWKK-BBANNHEPSA-N 0.000 description 1
- PPTYJKAXVCCBDU-UHFFFAOYSA-N Rohypnol Chemical compound N=1CC(=O)N(C)C2=CC=C([N+]([O-])=O)C=C2C=1C1=CC=CC=C1F PPTYJKAXVCCBDU-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 239000002174 Styrene-butadiene Substances 0.000 description 1
- KLBQZWRITKRQQV-UHFFFAOYSA-N Thioridazine Chemical compound C12=CC(SC)=CC=C2SC2=CC=CC=C2N1CCC1CCCCN1C KLBQZWRITKRQQV-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 230000037374 absorbed through the skin Effects 0.000 description 1
- 229960005142 alclofenac Drugs 0.000 description 1
- ARHWPKZXBHOEEE-UHFFFAOYSA-N alclofenac Chemical compound OC(=O)CC1=CC=C(OCC=C)C(Cl)=C1 ARHWPKZXBHOEEE-UHFFFAOYSA-N 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229960001301 amobarbital Drugs 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960003515 bendroflumethiazide Drugs 0.000 description 1
- HDWIHXWEUNVBIY-UHFFFAOYSA-N bendroflumethiazidum Chemical compound C1=C(C(F)(F)F)C(S(=O)(=O)N)=CC(S(N2)(=O)=O)=C1NC2CC1=CC=CC=C1 HDWIHXWEUNVBIY-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229960002537 betamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- MTAZNLWOLGHBHU-UHFFFAOYSA-N butadiene-styrene rubber Chemical compound C=CC=C.C=CC1=CC=CC=C1 MTAZNLWOLGHBHU-UHFFFAOYSA-N 0.000 description 1
- 229920005549 butyl rubber Polymers 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 description 1
- 229960003291 chlorphenamine Drugs 0.000 description 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
- 229960001076 chlorpromazine Drugs 0.000 description 1
- 229960004703 clobetasol propionate Drugs 0.000 description 1
- CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 description 1
- 229960002896 clonidine Drugs 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 239000011162 core material Substances 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 229960004138 cyclobarbital Drugs 0.000 description 1
- WTYGAUXICFETTC-UHFFFAOYSA-N cyclobarbital Chemical compound C=1CCCCC=1C1(CC)C(=O)NC(=O)NC1=O WTYGAUXICFETTC-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 229960002768 dipyridamole Drugs 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 238000007905 drug manufacturing Methods 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 229920006242 ethylene acrylic acid copolymer Polymers 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229960004369 flufenamic acid Drugs 0.000 description 1
- LPEPZBJOKDYZAD-UHFFFAOYSA-N flufenamic acid Chemical compound OC(=O)C1=CC=CC=C1NC1=CC=CC(C(F)(F)F)=C1 LPEPZBJOKDYZAD-UHFFFAOYSA-N 0.000 description 1
- 229960003469 flumetasone Drugs 0.000 description 1
- WXURHACBFYSXBI-GQKYHHCASA-N flumethasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]2(C)C[C@@H]1O WXURHACBFYSXBI-GQKYHHCASA-N 0.000 description 1
- 229960002200 flunitrazepam Drugs 0.000 description 1
- 229940043075 fluocinolone Drugs 0.000 description 1
- 229960000785 fluocinonide Drugs 0.000 description 1
- 229960002690 fluphenazine Drugs 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229960004391 lorazepam Drugs 0.000 description 1
- 229960003464 mefenamic acid Drugs 0.000 description 1
- HYYBABOKPJLUIN-UHFFFAOYSA-N mefenamic acid Chemical compound CC1=CC=CC(NC=2C(=CC=CC=2)C(O)=O)=C1C HYYBABOKPJLUIN-UHFFFAOYSA-N 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229960004815 meprobamate Drugs 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- OIXVKQDWLFHVGR-WQDIDPJDSA-N neomycin B sulfate Chemical compound OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO OIXVKQDWLFHVGR-WQDIDPJDSA-N 0.000 description 1
- 229960001454 nitrazepam Drugs 0.000 description 1
- KJONHKAYOJNZEC-UHFFFAOYSA-N nitrazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1 KJONHKAYOJNZEC-UHFFFAOYSA-N 0.000 description 1
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 1
- 229960001907 nitrofurazone Drugs 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229960000649 oxyphenbutazone Drugs 0.000 description 1
- HFHZKZSRXITVMK-UHFFFAOYSA-N oxyphenbutazone Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=C(O)C=C1 HFHZKZSRXITVMK-UHFFFAOYSA-N 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 229960002858 paramethasone Drugs 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229960000339 pentamycin Drugs 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229960002695 phenobarbital Drugs 0.000 description 1
- 229960002895 phenylbutazone Drugs 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920001289 polyvinyl ether Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229960002132 pyrrolnitrin Drugs 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000011115 styrene butadiene Substances 0.000 description 1
- 229920003048 styrene butadiene rubber Polymers 0.000 description 1
- 229960002673 sulfacetamide Drugs 0.000 description 1
- SKIVFJLNDNKQPD-UHFFFAOYSA-N sulfacetamide Chemical compound CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 SKIVFJLNDNKQPD-UHFFFAOYSA-N 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- 229960002784 thioridazine Drugs 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 229960005294 triamcinolone Drugs 0.000 description 1
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 description 1
- 229960002117 triamcinolone acetonide Drugs 0.000 description 1
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
æ¬çºæã¯æ°èŠãªè€åå»è¬è£œå€ã®è£œæ³ã«é¢ããã
ã®ã§ãæŽã«è©³ããã¯è£œé å·¥çšäžã«ãããè¬ç©ã®å
解ãæ倱䞊ã³ã«åŒç«ãç«çœãªã©ã®å±éºã®ãªãå Žå
å»è¬è£œå€ã®è£œæ³ãæäŸãããã®ã§ããã
ã®ã§ãæŽã«è©³ããã¯è£œé å·¥çšäžã«ãããè¬ç©ã®å
解ãæ倱䞊ã³ã«åŒç«ãç«çœãªã©ã®å±éºã®ãªãå Žå
å»è¬è£œå€ã®è£œæ³ãæäŸãããã®ã§ããã
å»è¬è£œå€ãšããŠã¯ããŽã åã³ïŒåã¯åææš¹èé¡
ãäž»äœãšããæå§æ§æ¥çç©è³ªã«è¬ç©ãé åããŠæ
æäœäžã«åœ¢æããŠãªããã®ããæ æäœãšè²Œçå€å±€
ãšã®éã«è¬ç©ä¿æå±€ã圢æããŠãªããã®ãç¥ãã
ãŠããã
ãäž»äœãšããæå§æ§æ¥çç©è³ªã«è¬ç©ãé åããŠæ
æäœäžã«åœ¢æããŠãªããã®ããæ æäœãšè²Œçå€å±€
ãšã®éã«è¬ç©ä¿æå±€ã圢æããŠãªããã®ãç¥ãã
ãŠããã
ãããã®å»è¬è£œå€ã¯ãäŸãã°ãåèšæ¥çç©è³ªãš
è¬ç©ãšãæ··åããå ¬ç¥ã®å¡åžæ段ãçšããŠæ æäœ
äžã«åœ¢æããé«æž©ã§å ç±ä¹Ÿç¥ããŠè£œé ããããã
ã«ã補é å·¥çšäžã§ã®è¬ç©ã®é£æ£ãå€è³ªããããã
ã®ããã«äºããããé£æ£ãå€è³ªã«ããè¬ç©ãæ倱
ãèŠèŸŒãã§é åããªããã°ãªããªããšããæ¬ ç¹ã
ããã
è¬ç©ãšãæ··åããå ¬ç¥ã®å¡åžæ段ãçšããŠæ æäœ
äžã«åœ¢æããé«æž©ã§å ç±ä¹Ÿç¥ããŠè£œé ããããã
ã«ã補é å·¥çšäžã§ã®è¬ç©ã®é£æ£ãå€è³ªããããã
ã®ããã«äºããããé£æ£ãå€è³ªã«ããè¬ç©ãæ倱
ãèŠèŸŒãã§é åããªããã°ãªããªããšããæ¬ ç¹ã
ããã
ãããæ¬ ç¹ã解決ããæ¹æ³ãçš®ã
ææ¡ãããŠã
ãã
ãã
ãã®äžã€ã¯æ
æäœäžã«æå§æ§æ¥çå€å±€ã圢æ
ãããã®å±€é¢ã«è¬ç©å«æ溶液ãå¡åžåã¯ã¹ãã¬ãŒ
ã«ãã€ãŠåœ¢æãããã®åŸäœæž©ä¹Ÿç¥ããæ¹æ³ã§ã
ãã
ãããã®å±€é¢ã«è¬ç©å«æ溶液ãå¡åžåã¯ã¹ãã¬ãŒ
ã«ãã€ãŠåœ¢æãããã®åŸäœæž©ä¹Ÿç¥ããæ¹æ³ã§ã
ãã
ããããŠããã®æ¹æ³ã§ã¯æº¶æ¶²äžã®è¬ç©æ¿åºŠãé«
ããšè¡šé¢ã§è¬ç©ãçµæ¶åããæ¥çå€å±€ã®æ¥çåã
äœäžããããšããåé¡ãèµ·çãããšå ±ã«ãæ®çºæ§
ã®è¬ç©ã§ã¯é£æ£ã®åé¡ã解決ã§ããªããã®ã§ã
ãã
ããšè¡šé¢ã§è¬ç©ãçµæ¶åããæ¥çå€å±€ã®æ¥çåã
äœäžããããšããåé¡ãèµ·çãããšå ±ã«ãæ®çºæ§
ã®è¬ç©ã§ã¯é£æ£ã®åé¡ã解決ã§ããªããã®ã§ã
ãã
ä»ã®æ¹æ³ã¯ãé¢åã©ã€ããŒäžã«åœ¢æãããŽã ç³»
ç²çå€å±€é¢ã«ããããã°ãªã»ãªã³ãç²çå€äžãšå
äžã®è»åå€æåã«é åããŠå¡åžãããã®äžã«ããª
ãªã¬ãã€ã³ç³»ãã€ã«ã ãéãåããçæããŠãè»
åå€æåã®ç²çå€å±€ãžã®ç§»è¡ãšå ±ã«ããããã°ãª
ã»ãªã³ãç²çå€å±€ãžç§»è¡ããããã®ã§ããã
ç²çå€å±€é¢ã«ããããã°ãªã»ãªã³ãç²çå€äžãšå
äžã®è»åå€æåã«é åããŠå¡åžãããã®äžã«ããª
ãªã¬ãã€ã³ç³»ãã€ã«ã ãéãåããçæããŠãè»
åå€æåã®ç²çå€å±€ãžã®ç§»è¡ãšå ±ã«ããããã°ãª
ã»ãªã³ãç²çå€å±€ãžç§»è¡ããããã®ã§ããã
ãã®æ¹æ³ã®æ倧ã®åé¡ã¯ãç²çå€å±€ãžã®è»åå€
æåã®ç§»è¡ãå®å šã«è¡ããã«ããããã«ãç²çå€
å±€ãšããªãªã¬ãã€ã³ç³»ãã€ã«ã ãšã®éã«å åãªæ¥
ç匷床ãåŸãããªãããšã§ããããããåé¡ã¯ã
ç²çå€å±€ãå åã«æ¶æ©ãããç³æ®ããªã©ãçããª
ãããã«èšèšãããŠãããšãã«ãè»åå€æåã®ç§»
è¡ãäžå®å šãšãªãæãããã«ãããå©é·ãããã
ã®ã§ããã
æåã®ç§»è¡ãå®å šã«è¡ããã«ããããã«ãç²çå€
å±€ãšããªãªã¬ãã€ã³ç³»ãã€ã«ã ãšã®éã«å åãªæ¥
ç匷床ãåŸãããªãããšã§ããããããåé¡ã¯ã
ç²çå€å±€ãå åã«æ¶æ©ãããç³æ®ããªã©ãçããª
ãããã«èšèšãããŠãããšãã«ãè»åå€æåã®ç§»
è¡ãäžå®å šãšãªãæãããã«ãããå©é·ãããã
ã®ã§ããã
åŸã€ãŠãæ¬çºæã®ç¬¬äžã®ç®çã¯ã補å€è£œé å·¥çš
äžã«ãããè¬ç©ã®æ倱åã¯å€è³ªããªããã補æ³ã
æäŸããããšã§ããã
äžã«ãããè¬ç©ã®æ倱åã¯å€è³ªããªããã補æ³ã
æäŸããããšã§ããã
æ¬çºæã®ç¬¬äºã®ç®çã¯ãè¬ç©ãçµæ¶åããã®ã
é²æ¢ãã補æ³ãæäŸããããšã§ããã
é²æ¢ãã補æ³ãæäŸããããšã§ããã
æ¬çºæã®ç¬¬äžã®ç®çã¯ãæ
æäœãšæå§æ§æ¥çå€
å±€ãšã®æ¥ç匷床ã匷ã補æ³ãæäŸããããšã§ã
ãã
å±€ãšã®æ¥ç匷床ã匷ã補æ³ãæäŸããããšã§ã
ãã
æ¬çºæã¯ããã«ããããã°ãªã»ãªã³ã®åŠãççº
æ§ãæããè¬ç©ãã«ã³ãã¢ãŒããµãªãã«é žã¡ã
ã«ãç¡é žã€ãœãœã«ãããŒã«ã®åŠãæ®çºæ§ã®é«ãè¬
ç©ãªã©ã®åãæ±ããç ©éãªè¬ç©ããå®å šäžã€å®å®
ããŠããããå¹çè¯ãåãæ±ãããšãã§ãã補æ³
ãæäŸãããã®ã§ããã
æ§ãæããè¬ç©ãã«ã³ãã¢ãŒããµãªãã«é žã¡ã
ã«ãç¡é žã€ãœãœã«ãããŒã«ã®åŠãæ®çºæ§ã®é«ãè¬
ç©ãªã©ã®åãæ±ããç ©éãªè¬ç©ããå®å šäžã€å®å®
ããŠããããå¹çè¯ãåãæ±ãããšãã§ãã補æ³
ãæäŸãããã®ã§ããã
ãããæ¬çºæã®ç®çã¯ãå®è³ªçã«è¬ç©ãæ¡æ£é
éããªãæ æäœã®è¡šé¢ã«é«ååç©è³ªå±€ã圢æããŠ
ãªãåºäœã®è©²å±€é¢ã«ãè¬ç©åã¯è¬ç©ãä¿æããæ
äœãéšååã¯å šé¢çã«ä»åšãããŠè¬ç©ãæ¡æ£ç§»å
ãããæå§æ§æ¥çå€èãå§çããåèšè¬ç©ãåèš
æ¥çå€èã«æ¡æ£ç§»åãããããšã«ãã€ãŠéæãã
ããã®ã§ããã
éããªãæ æäœã®è¡šé¢ã«é«ååç©è³ªå±€ã圢æããŠ
ãªãåºäœã®è©²å±€é¢ã«ãè¬ç©åã¯è¬ç©ãä¿æããæ
äœãéšååã¯å šé¢çã«ä»åšãããŠè¬ç©ãæ¡æ£ç§»å
ãããæå§æ§æ¥çå€èãå§çããåèšè¬ç©ãåèš
æ¥çå€èã«æ¡æ£ç§»åãããããšã«ãã€ãŠéæãã
ããã®ã§ããã
æ¬çºæã®å
·äœåããäžã€ã®æ
æ§ã¯ãå®è³ªçã«è¬
ç©ãæ¡æ£ééããªãæ æäœã®è¡šé¢ã«é«ååç©è³ªå±€
ã圢æããŠåºäœãäœãå·¥çšãšã該局é¢ã«è¬ç©å±€å
ã¯è¬ç©ãä¿æããæ äœå±€ãéšååã¯å šé¢çã«åœ¢æ
ããå·¥çšãšããããã®å±€é¢ã«ããã«è¬ç©ãæ¡æ£é
éãããæå§æ§æ¥çå€èã転çããŠã宀枩åã¯å¶
埡ããå ç±æž©åºŠäžã§å§çããè¬ç©ãæ¥çå€èã«æ¡
æ£ç§»åãããå·¥çšãããªãè€åå»è¬è£œå€ã®è£œæ³ã§
ããããã®è£œæ³ã¯ãè¬ç©ã«å šãæãã¯çŽæ¥ã«ç±ã
å ããããããšããªãã®ã§å解åã¯å€è³ªããªããš
å ±ã«ãè¬ç©åã¯è¬ç©ãä¿æããæ äœã¯åºäœãšæ¥ç
å€èãšã§ãµã³ãã€ãããããç¶æ ã§è£œé å·¥çšäžã
移åããããã«ãé£æ£åã¯èŒçºãããããšããª
ããè¬ç©ã®æ倱ããªãå»è¬è£œå€ãæäŸãããåºäœ
ãšæ¥çå€èãšã«ä»åšãããè¬ç©æåã¯ãç·©ãã«å
æž©ããããšã«ããçæéã§ããŸã宀枩ã§çæãã
ããšã«ããé·æéã§ãæ¥çå€èäžã«æ¡æ£ç§»åã
ããåèšå§çæäœã¯ãåºäœãæ§æããé«ååç©è³ª
å±€ãšæ¥çå€å±€ãšããè¬ç©å±€åã¯è¬ç©ãä¿æããæ
äœå±€ãä»ããŠäžäœçã«çµåããããã®ã§ããã
ç©ãæ¡æ£ééããªãæ æäœã®è¡šé¢ã«é«ååç©è³ªå±€
ã圢æããŠåºäœãäœãå·¥çšãšã該局é¢ã«è¬ç©å±€å
ã¯è¬ç©ãä¿æããæ äœå±€ãéšååã¯å šé¢çã«åœ¢æ
ããå·¥çšãšããããã®å±€é¢ã«ããã«è¬ç©ãæ¡æ£é
éãããæå§æ§æ¥çå€èã転çããŠã宀枩åã¯å¶
埡ããå ç±æž©åºŠäžã§å§çããè¬ç©ãæ¥çå€èã«æ¡
æ£ç§»åãããå·¥çšãããªãè€åå»è¬è£œå€ã®è£œæ³ã§
ããããã®è£œæ³ã¯ãè¬ç©ã«å šãæãã¯çŽæ¥ã«ç±ã
å ããããããšããªãã®ã§å解åã¯å€è³ªããªããš
å ±ã«ãè¬ç©åã¯è¬ç©ãä¿æããæ äœã¯åºäœãšæ¥ç
å€èãšã§ãµã³ãã€ãããããç¶æ ã§è£œé å·¥çšäžã
移åããããã«ãé£æ£åã¯èŒçºãããããšããª
ããè¬ç©ã®æ倱ããªãå»è¬è£œå€ãæäŸãããåºäœ
ãšæ¥çå€èãšã«ä»åšãããè¬ç©æåã¯ãç·©ãã«å
æž©ããããšã«ããçæéã§ããŸã宀枩ã§çæãã
ããšã«ããé·æéã§ãæ¥çå€èäžã«æ¡æ£ç§»åã
ããåèšå§çæäœã¯ãåºäœãæ§æããé«ååç©è³ª
å±€ãšæ¥çå€å±€ãšããè¬ç©å±€åã¯è¬ç©ãä¿æããæ
äœå±€ãä»ããŠäžäœçã«çµåããããã®ã§ããã
æ¬çºæã®æ
æ§ã«ã¯ãè¬ç©å±€åã¯è¬ç©ãä¿æãã
æ äœå±€ãéšååã¯å šé¢çã«æ¥çå€èäžã«åœ¢æãã
次ãã§åºäœã®é«ååç©è³ªå±€é¢ã«å§çããæ¹æ³ãæ
ãã¯åºäœãšãè¬ç©å±€åã¯è¬ç©ãä¿æããæ äœå±€
ãšãæ¥çå€èãšãå®è³ªçã«åæã«éãåºããŠå§ç
ããæ¹æ³ãªã©ãå å«ãããããšãç解ãããã§ã
ããã
æ äœå±€ãéšååã¯å šé¢çã«æ¥çå€èäžã«åœ¢æãã
次ãã§åºäœã®é«ååç©è³ªå±€é¢ã«å§çããæ¹æ³ãæ
ãã¯åºäœãšãè¬ç©å±€åã¯è¬ç©ãä¿æããæ äœå±€
ãšãæ¥çå€èãšãå®è³ªçã«åæã«éãåºããŠå§ç
ããæ¹æ³ãªã©ãå å«ãããããšãç解ãããã§ã
ããã
ããã«ãåºäœãæ§æããé«ååç©è³ªå±€ããæ
æ
äœã«çŽæ¥é«ååç©è³ªãå¡åžä¹Ÿç¥ãããŠæ§æããã
以å€ã«ãäºãé¢åã©ã€ããŒäžã§é«ååç©è³ªèãäœ
æããŠããããããæ æäœã®è¡šé¢ã«æº¶çãæ¥çå€
ãªã©ã®æ¥çæ段ãçšããŠæ¥çããŠæ§æãããå Ž
åãæãã¯æå§æ§æ¥çå€èãè¬ç©ãæ¡æ£ééãã
ããã®ã§ãããšããæ¡ä»¶ãæºè¶³ããããã®ã§ãã
ã°ãåžè²©ã®ç®èã«ç¡åºæ¿æ§ã®äž¡é¢æå§æ§æ¥çå€ã
ã€ã«ã ïŒãã€ã«ã ã«ã¬ãŒãšã³äžç¹åžã®åŠãè¬ç©ã®
æ¡æ£ééãé»å®³ããªãè¯æãå«æãããã®ãå«
ããïŒã䜿çšããå Žåããæ¬çºæã®æ æ§ã«å«ãŸã
ããã®ã§ããã
äœã«çŽæ¥é«ååç©è³ªãå¡åžä¹Ÿç¥ãããŠæ§æããã
以å€ã«ãäºãé¢åã©ã€ããŒäžã§é«ååç©è³ªèãäœ
æããŠããããããæ æäœã®è¡šé¢ã«æº¶çãæ¥çå€
ãªã©ã®æ¥çæ段ãçšããŠæ¥çããŠæ§æãããå Ž
åãæãã¯æå§æ§æ¥çå€èãè¬ç©ãæ¡æ£ééãã
ããã®ã§ãããšããæ¡ä»¶ãæºè¶³ããããã®ã§ãã
ã°ãåžè²©ã®ç®èã«ç¡åºæ¿æ§ã®äž¡é¢æå§æ§æ¥çå€ã
ã€ã«ã ïŒãã€ã«ã ã«ã¬ãŒãšã³äžç¹åžã®åŠãè¬ç©ã®
æ¡æ£ééãé»å®³ããªãè¯æãå«æãããã®ãå«
ããïŒã䜿çšããå Žåããæ¬çºæã®æ æ§ã«å«ãŸã
ããã®ã§ããã
æ¬çºæã®è€åå»è¬è£œå€ã®è£œæ³ã«çšããããåæ
æã«ã€ããŠèª¬æããã
æã«ã€ããŠèª¬æããã
æ
æäœãé«ååç©è³ªãè¬ç©ãè¬ç©ãä¿æããæ
äœåã³æå§æ§æ¥çå€çšææã¯è€åå»è¬è£œå€ã®ææ
ãšããŠèš±å®¹ããããã®ã§ããã°ç¹ã«å¶éãããã
ã®ã§ã¯ãªããããããŠããããã®çµã¿åãã¯éèŠ
ã§ãããäŸãã°æ æäœã¯åŸè¿°ããããã«ãŽã å
ã³ïŒåã¯åææš¹èé¡ããäž»ãšããŠæ§æããããã
è¬ç©ãšã®çµã¿åãã«ãããŠã¯ãçšããè¬ç©ãšã®é¢
ä¿ã«ãããŠããã®è¬ç©ãå®è³ªçã«æ¡æ£ééããªã
æ æäœãéžæããããšãéèŠã§ããããŸãé«åå
ç©è³ªå±€ãšæå§æ§æ¥çå€èãšã®çµã¿åãã¯ãå€ãã®
å Žå該ç©è³ªå±€ãããé«ãè¬ç©æº¶è§£åºŠãæããæ¥ç
å€èãéžæãããããäŸãã°æ¥çæèã®åã¿ãå€
ããã«åäœé¢ç©åœãã®è¬ç©éã倧ãããããå Žå
ã«ã¯ãäž¡è ã®è¬ç©æº¶è§£åºŠãåçåã¯ç©è³ªå±€ã®æ¹ã
é«ãèšå®ããŠããããã®ã§ããããã®ããã«æ§æ
ããè€åå»è¬è£œå€ã«ãããŠã¯ãç©è³ªå±€äžã«æ¡æ£ç§»
åã«ãã€ãŠç§»è¡ããè¬ç©ããæ¥çå€èäžã®è¬ç©ã
ç®èããåžåãããŠæžå°ããŠãããšãåŸã ã«æ¥ç
å€èã«ç§»è¡ããæ¥çå€èäžã®è¬ç©ãè£å ããã
äœåã³æå§æ§æ¥çå€çšææã¯è€åå»è¬è£œå€ã®ææ
ãšããŠèš±å®¹ããããã®ã§ããã°ç¹ã«å¶éãããã
ã®ã§ã¯ãªããããããŠããããã®çµã¿åãã¯éèŠ
ã§ãããäŸãã°æ æäœã¯åŸè¿°ããããã«ãŽã å
ã³ïŒåã¯åææš¹èé¡ããäž»ãšããŠæ§æããããã
è¬ç©ãšã®çµã¿åãã«ãããŠã¯ãçšããè¬ç©ãšã®é¢
ä¿ã«ãããŠããã®è¬ç©ãå®è³ªçã«æ¡æ£ééããªã
æ æäœãéžæããããšãéèŠã§ããããŸãé«åå
ç©è³ªå±€ãšæå§æ§æ¥çå€èãšã®çµã¿åãã¯ãå€ãã®
å Žå該ç©è³ªå±€ãããé«ãè¬ç©æº¶è§£åºŠãæããæ¥ç
å€èãéžæãããããäŸãã°æ¥çæèã®åã¿ãå€
ããã«åäœé¢ç©åœãã®è¬ç©éã倧ãããããå Žå
ã«ã¯ãäž¡è ã®è¬ç©æº¶è§£åºŠãåçåã¯ç©è³ªå±€ã®æ¹ã
é«ãèšå®ããŠããããã®ã§ããããã®ããã«æ§æ
ããè€åå»è¬è£œå€ã«ãããŠã¯ãç©è³ªå±€äžã«æ¡æ£ç§»
åã«ãã€ãŠç§»è¡ããè¬ç©ããæ¥çå€èäžã®è¬ç©ã
ç®èããåžåãããŠæžå°ããŠãããšãåŸã ã«æ¥ç
å€èã«ç§»è¡ããæ¥çå€èäžã®è¬ç©ãè£å ããã
åŸã€ãŠãæ¥çå€èã«å¯Ÿããè¬ç©è§£åºŠâ«é«ååç©
質局ã®è¬ç©æº¶è§£åºŠãåã³æ¥çå€èã®åãïŒé«åå
ç©è³ªå±€ã®åãã®é¢ä¿ãæºè¶³ãããããšã«ãã€ãŠé
å¹åã®å»è¬è£œå€ãããŸãæ¥çå€èã«å¯Ÿããè¬ç©æº¶
解床âªé«ååç©è³ªå±€ã«å¯Ÿããè¬ç©æº¶è§£åºŠãåã³æ¥
çå€èã®åãïŒé«ååç©è³ªå±€ã®åãã®é¢ä¿ãæºè¶³
ãããããšã«ãã€ãŠé å¹åã®å»è¬è£œå€ããããã«
ãŸãæ¥çå€èåã³é«ååç©è³ªå±€äžã®è¬ç©éã飜å
ç¶æ ïŒäœãæ¥çå€èã«å¯Ÿããè¬ç©æº¶è§£åºŠïŒé«åå
ç©è³ªã«å¯Ÿããè¬ç©æº¶è§£åºŠïŒãšããäžã€æ¥çå€èã®
åãïŒé«ååç©è³ªå±€ã®åãã®é¢ä¿ãæºè¶³ãããã
ãšã«ãã€ãŠéå¹äžã€æç¶åã®å»è¬è£œå€ã倫ã åŸã
ãããã®ã§ããããšãç解ãããã§ãããã
質局ã®è¬ç©æº¶è§£åºŠãåã³æ¥çå€èã®åãïŒé«åå
ç©è³ªå±€ã®åãã®é¢ä¿ãæºè¶³ãããããšã«ãã€ãŠé
å¹åã®å»è¬è£œå€ãããŸãæ¥çå€èã«å¯Ÿããè¬ç©æº¶
解床âªé«ååç©è³ªå±€ã«å¯Ÿããè¬ç©æº¶è§£åºŠãåã³æ¥
çå€èã®åãïŒé«ååç©è³ªå±€ã®åãã®é¢ä¿ãæºè¶³
ãããããšã«ãã€ãŠé å¹åã®å»è¬è£œå€ããããã«
ãŸãæ¥çå€èåã³é«ååç©è³ªå±€äžã®è¬ç©éã飜å
ç¶æ ïŒäœãæ¥çå€èã«å¯Ÿããè¬ç©æº¶è§£åºŠïŒé«åå
ç©è³ªã«å¯Ÿããè¬ç©æº¶è§£åºŠïŒãšããäžã€æ¥çå€èã®
åãïŒé«ååç©è³ªå±€ã®åãã®é¢ä¿ãæºè¶³ãããã
ãšã«ãã€ãŠéå¹äžã€æç¶åã®å»è¬è£œå€ã倫ã åŸã
ãããã®ã§ããããšãç解ãããã§ãããã
åææãäŸç€ºããã
(1) æ
æäœïŒäŸãã°ããªãšãã¬ã³ãããªãããã¬
ã³ãããªå¡©åããã«ãããªå¡©åãããªãã³ãã
ãªããã«ã¢ã«ã³ãŒã«ãããªãšã¹ãã«ãããªã¢ã
ãããšãã¬ã³âé ¢é žããã«å ±éåäœãå¡©åãã
ã«âå¡©åãããªãã³å ±éåäœãããªãã¿ãžãš
ã³ãã»ããã¢ã³ããªã©ãããªããã€ã«ã åã¯ã·
ãŒãïŒè¡šé¢ã«éå±èžçãããã®ãå«ãïŒãæã
ã¯éå±ç®åç¬åã¯ãããïŒã€ä»¥äžãç©å±€ããŠãª
ãç©å±€ãã€ã«ã åã¯ã·ãŒããªã©ãæããããé©
床ãªæè»æ§ãšèªå·±æ¯ææ§ãæããåã¿ã®ç¯å²
ïŒçŽïŒã300ÎŒïœïŒã§äœ¿çšãããã
ã³ãããªå¡©åããã«ãããªå¡©åãããªãã³ãã
ãªããã«ã¢ã«ã³ãŒã«ãããªãšã¹ãã«ãããªã¢ã
ãããšãã¬ã³âé ¢é žããã«å ±éåäœãå¡©åãã
ã«âå¡©åãããªãã³å ±éåäœãããªãã¿ãžãš
ã³ãã»ããã¢ã³ããªã©ãããªããã€ã«ã åã¯ã·
ãŒãïŒè¡šé¢ã«éå±èžçãããã®ãå«ãïŒãæã
ã¯éå±ç®åç¬åã¯ãããïŒã€ä»¥äžãç©å±€ããŠãª
ãç©å±€ãã€ã«ã åã¯ã·ãŒããªã©ãæããããé©
床ãªæè»æ§ãšèªå·±æ¯ææ§ãæããåã¿ã®ç¯å²
ïŒçŽïŒã300ÎŒïœïŒã§äœ¿çšãããã
(2) é«ååç©è³ªïŒäŸãã°ããªïŒã¡ã¿ïŒã¢ã¯ãªã«ã¬
ãŒããããªããã«ã¢ã«ãã«ãšãŒãã«ãããªãŠã¬
ã¿ã³ããšãã¬ã³âé ¢é žããã«å ±éåäœããšãã¬
ã³âã¢ã¯ãªã«é žå ±éåäœãã¹ãã¬ã³âã€ãœãã¬
ã³âã¹ãã¬ã³å ±éåäœãŽã ãã¹ãã¬ã³âãã¿ãž
ãšã³ãããªããã³ãŽã ãããªã€ãœããã¬ã³ãŽ
ã ãããã«ãŽã ãã·ãªã³ãŒã³ãŽã ã倩ç¶ãŽã ã
ã«ã«ããã·ããã«ããªããŒãªã©ã®æ°Žæº¶æ§é«åå
ç©è³ªãäž»äœãšããå«æ°Žã²ã«ãã¹ãã¬ã³âã€ãœã
ã¬ã³âã¹ãã¬ã³å ±éåäœãŽã ãšæ²¹ãšãããªãæ²¹
æ§ã²ã«ãªã©ãæãããããã奜ãŸããã¯Tgã
25ãâ60âã®ç¯å²ã«ãããã®ã§ãããTgã25
â以äžã§ã¯å¯ææ§ãäžå åã§ãããâ60â以äž
ã§ã¯å åãªç©çç匷床ãåŸãããªãã®ã§å¥œãŸã
ããªããã®ã§ããã
ãŒããããªããã«ã¢ã«ãã«ãšãŒãã«ãããªãŠã¬
ã¿ã³ããšãã¬ã³âé ¢é žããã«å ±éåäœããšãã¬
ã³âã¢ã¯ãªã«é žå ±éåäœãã¹ãã¬ã³âã€ãœãã¬
ã³âã¹ãã¬ã³å ±éåäœãŽã ãã¹ãã¬ã³âãã¿ãž
ãšã³ãããªããã³ãŽã ãããªã€ãœããã¬ã³ãŽ
ã ãããã«ãŽã ãã·ãªã³ãŒã³ãŽã ã倩ç¶ãŽã ã
ã«ã«ããã·ããã«ããªããŒãªã©ã®æ°Žæº¶æ§é«åå
ç©è³ªãäž»äœãšããå«æ°Žã²ã«ãã¹ãã¬ã³âã€ãœã
ã¬ã³âã¹ãã¬ã³å ±éåäœãŽã ãšæ²¹ãšãããªãæ²¹
æ§ã²ã«ãªã©ãæãããããã奜ãŸããã¯Tgã
25ãâ60âã®ç¯å²ã«ãããã®ã§ãããTgã25
â以äžã§ã¯å¯ææ§ãäžå åã§ãããâ60â以äž
ã§ã¯å åãªç©çç匷床ãåŸãããªãã®ã§å¥œãŸã
ããªããã®ã§ããã
ãããã®é«ååç©è³ªã¯ãæå§æ§æ¥çå€èãšå
åŠçã«èŠªåæ§ãæãããã®ãéžæãããå€ãã®
å Žååžžæž©ã§æå§æ§æ¥çæ§ãæããããã«èšèšã
ããã
åŠçã«èŠªåæ§ãæãããã®ãéžæãããå€ãã®
å Žååžžæž©ã§æå§æ§æ¥çæ§ãæããããã«èšèšã
ããã
åŸã€ãŠããããã®ç³»ã«ãããŠåäœã§ã¯å¿
èŠãš
ããç¹æ§äŸãã°TgãåŸãããªããã®ã¯ãä»ã®
ç³»ã®ãã®ãšçµã¿åããããäžè¬ã«ç¥ãããé å
å€ãæå®éæ·»å ããŠå¿ èŠãšããç¹æ§ã«èª¿æŽãã
ããã®ã§ããããŸãè¬ç©ã®ç§»è¡éã調æŽãã
ãã補å€ã®ä¿åæ§ã®ããã«ãååŠçæãã¯ç©ç
çãªæ¶æ©ææ³ãçšããŠæ¶æ©ããŠããããã®ã§ã
ãã
ããç¹æ§äŸãã°TgãåŸãããªããã®ã¯ãä»ã®
ç³»ã®ãã®ãšçµã¿åããããäžè¬ã«ç¥ãããé å
å€ãæå®éæ·»å ããŠå¿ èŠãšããç¹æ§ã«èª¿æŽãã
ããã®ã§ããããŸãè¬ç©ã®ç§»è¡éã調æŽãã
ãã補å€ã®ä¿åæ§ã®ããã«ãååŠçæãã¯ç©ç
çãªæ¶æ©ææ³ãçšããŠæ¶æ©ããŠããããã®ã§ã
ãã
ãã®ããã«èª¿æŽããé«ååç©è³ªã¯ãåèšæ
æ
äœã®è¡šé¢ã«ãçŽïŒã300ÎŒïœã®åã¿ã§æ§æãã
ãã
äœã®è¡šé¢ã«ãçŽïŒã300ÎŒïœã®åã¿ã§æ§æãã
ãã
(3) è¬ç©ïŒäŸãã°
(ã€) ã³ã«ãã³ã¹ããã€ãé¡ïŒäŸãã°ãã€ããã³
ãŒããŸã³ããã¬ãããŸãã³ããã©ã¡ã¿ãŸã³ã
ãã¯ãã¡ã¿ãŸã³ããããªããŒãããã«ã¡ã¿ãŸ
ã³ãããŒã¿ã¡ã¿ãŸã³ãããããªã³é žãã¯ãã¡
ã¿ãŸã³ããããµã¡ã¿ãŸã³ãããªã¢ã ã·ãã
ã³ãããªã¢ã ã·ããã³ã¢ã»ãããããã«ãªã·
ããã³ããã«ãªã·ããã³ã¢ã»ãããããã«ãª
ã·ããã³ã¢ã»ãããã¢ã»ããŒããããããªã³
é žã¯ããã¿ãŸãŒã«ãªã©ã (ã) é®çæ¶çå€ïŒäŸãã°ã¢ã»ãã¢ããããšã³ã
ã¡ããšãã é žããã«ããšãã é žãã€ã³ãã¡ã¿
ã·ã³ããžã¯ãããšããã¯ãã¢ã«ã¯ãããšãã
ã¯ããªãã·ããšã³ãã¿ãŸã³ãããšãã«ãã¿ãŸ
ã³ãã€ãããããšã³ããã«ã«ããããšã³ããµ
ãªãã«é žããµãªãã«é žã¡ãã«ããµãã³ãŒã«ã
ã«ã³ãã¢ãŒãïœâã¡ã³ããŒã«ãªã©ã (ã) å¬ç é®éå€ïŒäŸãã°ããšããã«ãã¿ãŒã«ã
ã¢ã¢ãã«ãã¿ãŒã«ãã·ã¯ããã«ãã¿ãŒã«ãª
ã©ã (ã) 粟ç¥å®å®å€ïŒäŸãã°ãã«ããšããžã³ãããª
ãªããžã³ããžã¢ãŒãã ããã©ãŒãã ããã«ã
ãã©ãŒãã ãã¯ãã«ããããžã³ãªã©ã (ã) æé«è¡å§å€ïŒäŸãã°ã¯ãããžã³ãã«ãªã¯ã¬
ã€ã³ãªã©ã (ã) éå§å©å°¿å€ïŒäŸãã°ãã€ãããµã€ã¢ã¶ã€
ãããã³ãããã«ã¡ãµã€ã¢ã¶ã€ããªã©ã (ã) æçç©è³ªïŒäŸãã°ããã·ãªã³ããªãã·ãã
ã©ãµã€ã¯ãªã³ãç¡«é žãã©ãžãªãã€ã·ã³ããšãª
ã¹ããã€ã·ã³ãã¯ãã©ã ããšãã³ãŒã«ãªã© (ã) 麻é å€ïŒäŸãã°ãªãã«ã€ã³ããã³ãŸã«ã€
ã³ãã¢ããå®æ¯éŠé žãšãã«ãªã©ã (ãª) æèæ§ç©è³ªïŒäŸãã°å¡©åãã³ã¶ã«ã³ããŠ
ã ãããããã©ãŸã³ããã€ã¹ãã¿ã³ãã¢ã»ã
ã¹ã«ãã¢ãã³ãã¯ãããªããŸãŒã«ãªã©ã (ã) æçèç©è³ªïŒäŸãã°ãã³ã¿ãã€ã·ã³ãã¢
ã ãããªã·ã³ïŒ¢ããããŒã«ãããªã³ãªã©ã (ã«) ãã¿ãã³å€ïŒäŸãã°ãã¿ãã³ïŒ¡ããšã«ãŽ
ã«ã«ã·ããšããŒã«ãã³ã¬ã«ã«ã·ããšããŒã«ã
ãªã¯ããã¢ãã³ããªããã©ãã³é ªé žãšã¹ãã«
ãªã©ã (ã²) æãŠãããå€ïŒäŸãã°ããã©ãŒãã ãã¡
ãããã¡ãŒããªã©ã (ã¯) å è¡ç®¡æ¡åŒµå€ïŒäŸãã°ãããã°ãªã»ãª
ã³ããžããªãã¢ãŒã«ãã€ãœãœã«ãã€ããžãã€
ãã¬ãŒãããã³ã¿ãšãªã¹ãªããŒã¹ããã©ãã
ã¬ã€ããããããã«ããã¬ãŒãããããšãžã
ã³ãªã©ã (ã«) æãã¹ã¿ãã³å€ïŒäŸãã°å¡©é žãžããšã³ã
ãã©ãã³ãã¯ãã«ããšãã©ãã³ããžããšãã«
ã€ãããŸãŒã«ãªã©ã ãããã®è¬ç©ã¯å¿ èŠã«å¿ããŠïŒçš®ä»¥äžäœµçšã
ãããšãã§ããã
ãŒããŸã³ããã¬ãããŸãã³ããã©ã¡ã¿ãŸã³ã
ãã¯ãã¡ã¿ãŸã³ããããªããŒãããã«ã¡ã¿ãŸ
ã³ãããŒã¿ã¡ã¿ãŸã³ãããããªã³é žãã¯ãã¡
ã¿ãŸã³ããããµã¡ã¿ãŸã³ãããªã¢ã ã·ãã
ã³ãããªã¢ã ã·ããã³ã¢ã»ãããããã«ãªã·
ããã³ããã«ãªã·ããã³ã¢ã»ãããããã«ãª
ã·ããã³ã¢ã»ãããã¢ã»ããŒããããããªã³
é žã¯ããã¿ãŸãŒã«ãªã©ã (ã) é®çæ¶çå€ïŒäŸãã°ã¢ã»ãã¢ããããšã³ã
ã¡ããšãã é žããã«ããšãã é žãã€ã³ãã¡ã¿
ã·ã³ããžã¯ãããšããã¯ãã¢ã«ã¯ãããšãã
ã¯ããªãã·ããšã³ãã¿ãŸã³ãããšãã«ãã¿ãŸ
ã³ãã€ãããããšã³ããã«ã«ããããšã³ããµ
ãªãã«é žããµãªãã«é žã¡ãã«ããµãã³ãŒã«ã
ã«ã³ãã¢ãŒãïœâã¡ã³ããŒã«ãªã©ã (ã) å¬ç é®éå€ïŒäŸãã°ããšããã«ãã¿ãŒã«ã
ã¢ã¢ãã«ãã¿ãŒã«ãã·ã¯ããã«ãã¿ãŒã«ãª
ã©ã (ã) 粟ç¥å®å®å€ïŒäŸãã°ãã«ããšããžã³ãããª
ãªããžã³ããžã¢ãŒãã ããã©ãŒãã ããã«ã
ãã©ãŒãã ãã¯ãã«ããããžã³ãªã©ã (ã) æé«è¡å§å€ïŒäŸãã°ã¯ãããžã³ãã«ãªã¯ã¬
ã€ã³ãªã©ã (ã) éå§å©å°¿å€ïŒäŸãã°ãã€ãããµã€ã¢ã¶ã€
ãããã³ãããã«ã¡ãµã€ã¢ã¶ã€ããªã©ã (ã) æçç©è³ªïŒäŸãã°ããã·ãªã³ããªãã·ãã
ã©ãµã€ã¯ãªã³ãç¡«é žãã©ãžãªãã€ã·ã³ããšãª
ã¹ããã€ã·ã³ãã¯ãã©ã ããšãã³ãŒã«ãªã© (ã) 麻é å€ïŒäŸãã°ãªãã«ã€ã³ããã³ãŸã«ã€
ã³ãã¢ããå®æ¯éŠé žãšãã«ãªã©ã (ãª) æèæ§ç©è³ªïŒäŸãã°å¡©åãã³ã¶ã«ã³ããŠ
ã ãããããã©ãŸã³ããã€ã¹ãã¿ã³ãã¢ã»ã
ã¹ã«ãã¢ãã³ãã¯ãããªããŸãŒã«ãªã©ã (ã) æçèç©è³ªïŒäŸãã°ãã³ã¿ãã€ã·ã³ãã¢
ã ãããªã·ã³ïŒ¢ããããŒã«ãããªã³ãªã©ã (ã«) ãã¿ãã³å€ïŒäŸãã°ãã¿ãã³ïŒ¡ããšã«ãŽ
ã«ã«ã·ããšããŒã«ãã³ã¬ã«ã«ã·ããšããŒã«ã
ãªã¯ããã¢ãã³ããªããã©ãã³é ªé žãšã¹ãã«
ãªã©ã (ã²) æãŠãããå€ïŒäŸãã°ããã©ãŒãã ãã¡
ãããã¡ãŒããªã©ã (ã¯) å è¡ç®¡æ¡åŒµå€ïŒäŸãã°ãããã°ãªã»ãª
ã³ããžããªãã¢ãŒã«ãã€ãœãœã«ãã€ããžãã€
ãã¬ãŒãããã³ã¿ãšãªã¹ãªããŒã¹ããã©ãã
ã¬ã€ããããããã«ããã¬ãŒãããããšãžã
ã³ãªã©ã (ã«) æãã¹ã¿ãã³å€ïŒäŸãã°å¡©é žãžããšã³ã
ãã©ãã³ãã¯ãã«ããšãã©ãã³ããžããšãã«
ã€ãããŸãŒã«ãªã©ã ãããã®è¬ç©ã¯å¿ èŠã«å¿ããŠïŒçš®ä»¥äžäœµçšã
ãããšãã§ããã
(4) è¬ç©ãä¿æããæ
äœ
æ
äœã¯ãè¬ç©ãäžæçã«ä¿æãããã®ã§ãã€
ãŠãåžžæ ã§æ¶²ç¶ãååºåœ¢ç¶åã¯åºåœ¢ç¶ã®ããã
ã§ãè¯ããã®ã§ããã
ãŠãåžžæ ã§æ¶²ç¶ãååºåœ¢ç¶åã¯åºåœ¢ç¶ã®ããã
ã§ãè¯ããã®ã§ããã
æ
äœã¯ãæå§æ§æ¥çå€èãšã®é¢ä¿ã«ãããŠã
æ¥çå€èã®è¬ç©æº¶è§£åºŠïŒæ äœã®è¬ç©æº¶è§£åºŠã®é¢
ä¿ãæºè¶³ãããããã«éžæãããããšãæãŸã
ãã
æ¥çå€èã®è¬ç©æº¶è§£åºŠïŒæ äœã®è¬ç©æº¶è§£åºŠã®é¢
ä¿ãæºè¶³ãããããã«éžæãããããšãæãŸã
ãã
液ç¶ã®æ
äœãšããŠã¯ãæµåãã©ãã€ã³ãã¢ã«
ã³ãŒã«ãä¹³åå€ãé£çšæ²¹ãªã©ãæããããšãã§
ããã
ã³ãŒã«ãä¹³åå€ãé£çšæ²¹ãªã©ãæããããšãã§
ããã
ååºåœ¢ç¶ã®æ
äœãšããŠã¯ãã°ãªã»ãªã³ãã©ã
ãªã³ãäœèç¹ã¯ãã¯ã¹ãå¯ããŠãã¢ãããŒã«æš¹
èãªã©ã®é«ç²åºŠæ¶²ç¶æš¹èã液ç¶ãŽã ãä¹³åå€ãª
ã©ãæããããšãã§ããã
ãªã³ãäœèç¹ã¯ãã¯ã¹ãå¯ããŠãã¢ãããŒã«æš¹
èãªã©ã®é«ç²åºŠæ¶²ç¶æš¹èã液ç¶ãŽã ãä¹³åå€ãª
ã©ãæããããšãã§ããã
ãããã®åžžæ
ã§æ¶²ç¶åã¯ååºåœ¢ç¶ã®æ
äœãšè¬
ç©ãšã¯æ··åãããè¬ç©ãä¿æããæ äœãšãã
ãã
ç©ãšã¯æ··åãããè¬ç©ãä¿æããæ äœãšãã
ãã
ãŸãåžžæ
ã§åºåœ¢ç¶ã®æ
äœã¯ã倧å¥ããŠäºã€ã®
ç³»ã«åããããšãã§ããããã®äžã€ã¯ãã·ãŒã
åã¯ãã€ã«ã ç¶ç©ã§ãã€ãŠãäŸãã°ãã©ã¹ãã
ã¯ã·ãŒãåã¯ãã€ã«ã ãäžç¹åžãç¹åžãç·šåž
çŽãçºæ³¡ãã€ã«ã åã¯ã·ãŒãåã¯ãããã®æ§é
ç©ã§å·šèŠçãªåãæãããããç¶ç©ãªã©ãæã
ãããåã¿ã¯çŽïŒã300ÎŒïœã®ç¯å²ã«ãããã®
ã奜ãŸãããã®ã§ãããä»ã®äžã€ã¯ç²äœç¶ã®ã
ã®ã§ãã€ãŠããã®çŽ æã¯æ®ã«å¶éããããã®ã§
ã¯ãªããäŸãã°ç¡æ©åã¯ææ©ç©ãããªãå€å質
ç²æ«ãåç³é¡ãå€ç³é¡ãå æ¥ååç©ãªã©ãå«ãŸ
ãããã®ã§ããããã®åŸã¯çŽ0.001ã500ÎŒïœã®
ç¯å²ã«ãããã®ã奜é©ã§ããã
ç³»ã«åããããšãã§ããããã®äžã€ã¯ãã·ãŒã
åã¯ãã€ã«ã ç¶ç©ã§ãã€ãŠãäŸãã°ãã©ã¹ãã
ã¯ã·ãŒãåã¯ãã€ã«ã ãäžç¹åžãç¹åžãç·šåž
çŽãçºæ³¡ãã€ã«ã åã¯ã·ãŒãåã¯ãããã®æ§é
ç©ã§å·šèŠçãªåãæãããããç¶ç©ãªã©ãæã
ãããåã¿ã¯çŽïŒã300ÎŒïœã®ç¯å²ã«ãããã®
ã奜ãŸãããã®ã§ãããä»ã®äžã€ã¯ç²äœç¶ã®ã
ã®ã§ãã€ãŠããã®çŽ æã¯æ®ã«å¶éããããã®ã§
ã¯ãªããäŸãã°ç¡æ©åã¯ææ©ç©ãããªãå€å質
ç²æ«ãåç³é¡ãå€ç³é¡ãå æ¥ååç©ãªã©ãå«ãŸ
ãããã®ã§ããããã®åŸã¯çŽ0.001ã500ÎŒïœã®
ç¯å²ã«ãããã®ã奜é©ã§ããã
ãããã®åºåœ¢ç¶ã®æ
äœã«ã¯ãè¬ç©åç¬ã§åã¯
è¬ç©ãåäžã«åæ£åã¯æº¶è§£ãã溶åªãçšããŠã
å¡åžãå«æµžåéã¯åžçãªã©ãããè¬ç©ãä¿æã
ãæ äœãšãããã溶åªãšããŠã¯ãåŸè¿°ããå©å€
以å€ã«ãåèšã®åžžæ ã§æ¶²ç¶åã¯ååºåœ¢ç¶ã®æ äœ
ãçšããããããšãç解ãããã§ãããã
è¬ç©ãåäžã«åæ£åã¯æº¶è§£ãã溶åªãçšããŠã
å¡åžãå«æµžåéã¯åžçãªã©ãããè¬ç©ãä¿æã
ãæ äœãšãããã溶åªãšããŠã¯ãåŸè¿°ããå©å€
以å€ã«ãåèšã®åžžæ ã§æ¶²ç¶åã¯ååºåœ¢ç¶ã®æ äœ
ãçšããããããšãç解ãããã§ãããã
æ
äœäžã«ä¿æãããè¬ç©éã¯ãè¬ç©ã®çš®é¡
ïŒæå¹è¡äžæ¿åºŠãå«ããŠïŒä»¥å€ã«ãæ äœãšæ¥ç
ãããæ¥çå€èã®åã¿ãæãã¯æçµç©åããè€
åå»è¬è£œå€ã®åäœé¢ç©åœãã®è¬ç©éïŒçŽïŒã
3000ÎŒïœ/cm2ïŒãªã©ã«ãã€ãŠæ±ºãããããã®ã§
ããã
ïŒæå¹è¡äžæ¿åºŠãå«ããŠïŒä»¥å€ã«ãæ äœãšæ¥ç
ãããæ¥çå€èã®åã¿ãæãã¯æçµç©åããè€
åå»è¬è£œå€ã®åäœé¢ç©åœãã®è¬ç©éïŒçŽïŒã
3000ÎŒïœ/cm2ïŒãªã©ã«ãã€ãŠæ±ºãããããã®ã§
ããã
(5) æå§æ§æ¥çå€è
該æ¥çå€èãšããŠã¯ãè¬ç©ãæ¡æ£ééããç®
èã«å¯ŸããŠç¡åºæ¿æ§ã®åžžæž©ã§æå§æ¥çæ§ã®ç©è³ª
ã䜿çšãããã該ç©è³ªã¯ãã¹ãã¬ã³âã€ãœãã¬
ã³âã¹ãã¬ã³ãããã¯å ±éåäœãŽã ãã·ãªã³ãŒ
ã³ãŽã ã倩ç¶ãŽã ã®åŠãåã³ïŒåã¯ããªã¢ã¯ãª
ã¬ãŒããããªããã«ãšãŒãã«ã®åŠãåææš¹èãª
ã©ãäž»äœãšãããã®ã§ããã
èã«å¯ŸããŠç¡åºæ¿æ§ã®åžžæž©ã§æå§æ¥çæ§ã®ç©è³ª
ã䜿çšãããã該ç©è³ªã¯ãã¹ãã¬ã³âã€ãœãã¬
ã³âã¹ãã¬ã³ãããã¯å ±éåäœãŽã ãã·ãªã³ãŒ
ã³ãŽã ã倩ç¶ãŽã ã®åŠãåã³ïŒåã¯ããªã¢ã¯ãª
ã¬ãŒããããªããã«ãšãŒãã«ã®åŠãåææš¹èãª
ã©ãäž»äœãšãããã®ã§ããã
æ¥çå€èã«ã¯ãè¬ç©ãæ¡æ£ééããããšãšç®
èã«å¯ŸããŠç¡åºæ¿æ§ã§ããããšä»¥å€ã«ã補å€ã
ç®èã«é©çšåŸé€å»ãããšãã«ç®èã«æ®çç©ãæ®
ããªãããšåã³é€å»æã«ç©ççãªç®èåºæ¿ãäž
ããªãããšãæãŸãããã®ã§ãã€ãŠããããè«ž
èŠæ±ã¯Tgãâ75ãâ10âã®æå§æ¥çæ§ç©è³ªã
çšããããšã«ãã€ãŠéæããããã®ã§ããã
èã«å¯ŸããŠç¡åºæ¿æ§ã§ããããšä»¥å€ã«ã補å€ã
ç®èã«é©çšåŸé€å»ãããšãã«ç®èã«æ®çç©ãæ®
ããªãããšåã³é€å»æã«ç©ççãªç®èåºæ¿ãäž
ããªãããšãæãŸãããã®ã§ãã€ãŠããããè«ž
èŠæ±ã¯Tgãâ75ãâ10âã®æå§æ¥çæ§ç©è³ªã
çšããããšã«ãã€ãŠéæããããã®ã§ããã
æ¬çºæè
ã®å®éšã«ããã°ãç®èãžã®å¯çæ§ã
è¬ç©ãšã®æº¶è§£æ§åã³è¬ç©ã®æŸåºæ§ã®åèŠä»¶ãã
æã確å®ã«äžã€æ¯èŒçç°¡åãªè£œé æäœã§æºè¶³ã
ããæå§æ§æ¥çå€èã¯ãééå¹³åååéã1000
ã1000000ã®ã¢ã¯ãªã«ç³»å ±éåç©ããåŸããã
ãã®ã§ããããšãå€æããã
è¬ç©ãšã®æº¶è§£æ§åã³è¬ç©ã®æŸåºæ§ã®åèŠä»¶ãã
æã確å®ã«äžã€æ¯èŒçç°¡åãªè£œé æäœã§æºè¶³ã
ããæå§æ§æ¥çå€èã¯ãééå¹³åååéã1000
ã1000000ã®ã¢ã¯ãªã«ç³»å ±éåç©ããåŸããã
ãã®ã§ããããšãå€æããã
奜ãŸããã¢ã¯ãªã«ç³»å
±éåç©ã¯ã次ã®é
åçµ
æãããªããã®ã§ããã
æãããªããã®ã§ããã
å³ã¡ãã¢ã«ãã«åºã®å¹³åæ°ãïŒä»¥äžã®ïŒã¡
ã¿ïŒã¢ã¯ãªã«é žã¢ã«ãã«ãšã¹ãã«ãå°ãªããšã
50ééïŒ å«ãã¢ã¯ãªã«ç³»å ±éåç©ã§ããã
ã¿ïŒã¢ã¯ãªã«é žã¢ã«ãã«ãšã¹ãã«ãå°ãªããšã
50ééïŒ å«ãã¢ã¯ãªã«ç³»å ±éåç©ã§ããã
該å
±éåç©ã¯ãç®èãžã®å¯çæ§åã³è¬ç©ã«å¯Ÿ
ãã溶解æ§ãè¯å¥œã§ããããããç®èãåºæ¿ã
ãããšãå°ãªããè¬ç©ãå®å®çã«ä¿æããã
ãã溶解æ§ãè¯å¥œã§ããããããç®èãåºæ¿ã
ãããšãå°ãªããè¬ç©ãå®å®çã«ä¿æããã
åèšå
±éåç©ã«ã¯ïŒã¡ã¿ïŒã¢ã¯ãªã«é
žã¢ã«ã
ã«ãšã¹ãã«ãšä»ã®å ±éåå¯èœãªç®¡èœæ§ã¢ãããŒ
ãšã®å ±éåç©ãå«ããã®ã§ããã該ã¢ãããŒã¯
ïŒã20ééïŒ ã奜ãŸããã¯0.5ã15ééïŒ ã®ç¯
å²ã§é åãããã
ã«ãšã¹ãã«ãšä»ã®å ±éåå¯èœãªç®¡èœæ§ã¢ãããŒ
ãšã®å ±éåç©ãå«ããã®ã§ããã該ã¢ãããŒã¯
ïŒã20ééïŒ ã奜ãŸããã¯0.5ã15ééïŒ ã®ç¯
å²ã§é åãããã
該ã¢ãããŒã¯ããã®æ·»å éšæ°ã«ãã€ãŠå
±éå
ç©ã®åéæ§ãå€åãããããšãã§ããã®ã§ã補
å€ããã®è¬ç©ã®æŸåºé床åã¯éãå¶åŸ¡ã§ãããŸ
ãã¢ãããŒã®çš®é¡ãéžæããããšã«ãã€ãŠå ±é
åç©ã®èŠªæ°Žèœãé«ããããšãã§ããã
ç©ã®åéæ§ãå€åãããããšãã§ããã®ã§ã補
å€ããã®è¬ç©ã®æŸåºé床åã¯éãå¶åŸ¡ã§ãããŸ
ãã¢ãããŒã®çš®é¡ãéžæããããšã«ãã€ãŠå ±é
åç©ã®èŠªæ°Žèœãé«ããããšãã§ããã
ããã«åèšã®å
±éåç©ã«ã¯ïŒã¡ã¿ïŒã¢ã¯ãªã«
é žã¢ã«ãã«ãšã¹ãã«ãšä»ã®å ±éåå¯èœãªããã«
ãšã¹ãã«ã¢ãããŒãšã®å ±éåç©ããå«ããã®ã§
ããã該ã¢ãããŒã¯ïŒã40ééïŒ ã奜ãŸããã¯
10ã30ééïŒ ã®ç¯å²ã§é åãããã該ã¢ãããŒ
ãå«ãå ±éåç©ã¯è¬ç©ã®æº¶è§£æ§ãé«ããã®ã§ã
ãã
é žã¢ã«ãã«ãšã¹ãã«ãšä»ã®å ±éåå¯èœãªããã«
ãšã¹ãã«ã¢ãããŒãšã®å ±éåç©ããå«ããã®ã§
ããã該ã¢ãããŒã¯ïŒã40ééïŒ ã奜ãŸããã¯
10ã30ééïŒ ã®ç¯å²ã§é åãããã該ã¢ãããŒ
ãå«ãå ±éåç©ã¯è¬ç©ã®æº¶è§£æ§ãé«ããã®ã§ã
ãã
ãããã€ãŠå°ãªããšã50ééïŒ
ã®ïŒã¡ã¿ïŒã¢
ã¯ãªã«é žã¢ã«ãã«ãšã¹ãã«ãšãïŒã20ééïŒ ã®
åèšãšã¹ãã«é¡ãšå ±éåå¯èœãªå®èœæ§ã¢ãããŒ
ãšãïŒã40ééïŒ ã®åèšãšã¹ãã«é¡ãšå ±éåå¯
èœãªããã«ãšã¹ãã«ã¢ãããŒãšãäž»äœãšããã¢
ã¯ãªã«ç³»å ±éåç©ãããªãæå§æ§æ¥çå€èã¯ã
è¬ç©ãçµç®åžåãããæ¥çå€èãšããŠå¥œé©ãªã
ã®ã§ããããšãç解ãããã§ãããã
ã¯ãªã«é žã¢ã«ãã«ãšã¹ãã«ãšãïŒã20ééïŒ ã®
åèšãšã¹ãã«é¡ãšå ±éåå¯èœãªå®èœæ§ã¢ãããŒ
ãšãïŒã40ééïŒ ã®åèšãšã¹ãã«é¡ãšå ±éåå¯
èœãªããã«ãšã¹ãã«ã¢ãããŒãšãäž»äœãšããã¢
ã¯ãªã«ç³»å ±éåç©ãããªãæå§æ§æ¥çå€èã¯ã
è¬ç©ãçµç®åžåãããæ¥çå€èãšããŠå¥œé©ãªã
ã®ã§ããããšãç解ãããã§ãããã
(6) åèšé«ååç©è³ªå±€åã³æå§æ§æ¥çå€èã«ã¯ã
å¿ èŠã«å¿ããŠä»ã®é åå€ãæ·»å ããããšãã§ã
ããäž¡è ã«å ±éããŠé åããããã®ãšããŠã¯ã
æ¥çæ§ä»äžæš¹èãè»åå€ãå å¡«å€ãé¡æãªã©ã
äŸç€ºããããšãã§ããæ¥çå€èã«ã¯æŽã«è¬ç©ã®
æŸåºæ§åã³çµç®åžåæ§ãé«ããå©å€ãé åãã
ããšãã§ããã
å¿ èŠã«å¿ããŠä»ã®é åå€ãæ·»å ããããšãã§ã
ããäž¡è ã«å ±éããŠé åããããã®ãšããŠã¯ã
æ¥çæ§ä»äžæš¹èãè»åå€ãå å¡«å€ãé¡æãªã©ã
äŸç€ºããããšãã§ããæ¥çå€èã«ã¯æŽã«è¬ç©ã®
æŸåºæ§åã³çµç®åžåæ§ãé«ããå©å€ãé åãã
ããšãã§ããã
æ¬çºæã®è€åå»è¬è£œå€ã®è£œæ³ã¯ãåºæã®é«åå
ç©è³ªå±€ãšæå§æ§æ¥çå€èãšã®éã«ãè¬ç©åã¯è¬ç©
ãä¿æããæ äœãéšååã¯å šé¢çã«ä»åšãããŠå§
çããè¬ç©ãæ¥çå€èäžã«æ¡æ£ç§»åããããã®ã§
ããããã (1) 補å€è£œé å·¥çšäžã«ãããè¬ç©ã®æ倱åã¯å€è³ª
ãå šããªãã
ç©è³ªå±€ãšæå§æ§æ¥çå€èãšã®éã«ãè¬ç©åã¯è¬ç©
ãä¿æããæ äœãéšååã¯å šé¢çã«ä»åšãããŠå§
çããè¬ç©ãæ¥çå€èäžã«æ¡æ£ç§»åããããã®ã§
ããããã (1) 補å€è£œé å·¥çšäžã«ãããè¬ç©ã®æ倱åã¯å€è³ª
ãå šããªãã
(2) è¬ç©ã¯æ¥çå€èãåã¯èŠããã°é«ååç©è³ªå±€
ãžæ¡æ£ééãããŠç§»è¡ãããã®ã§ããããçµæ¶
åããªãã
ãžæ¡æ£ééãããŠç§»è¡ãããã®ã§ããããçµæ¶
åããªãã
(3) é«ååç©è³ªãšæ¥çå€èãšã¯ãå§çæäœã«ãã€
ãŠçŽæ¥åã¯æ äœãä»ããŠäžäœåããããã®ã§ã
ãããäž¡è ã®æ¥çã¯åŒ·åºã§ããã
ãŠçŽæ¥åã¯æ äœãä»ããŠäžäœåããããã®ã§ã
ãããäž¡è ã®æ¥çã¯åŒ·åºã§ããã
(4) ãããã°ãªã»ãªã³ã®åŠãççºæ§ã®è¬ç©ã«ãã
ãŠã¯æ äœã«åžçãªã©ãããŠçšããããšãã§ãã
ã®ã§å®å šã§ããã
ãŠã¯æ äœã«åžçãªã©ãããŠçšããããšãã§ãã
ã®ã§å®å šã§ããã
ãªã©ã®çš®ã
ã®ç¹åŸŽãæãããã®ã§ããã
以äžæ¬çºæã®å®æœäŸã瀺ããæäžéšãšããã®ã¯
éééšãæå³ããã
éééšãæå³ããã
å®æœäŸ ïŒ
ïŒã€å£ãã©ã¹ã³ã«ã94éšã®ïŒâãšãã«ããã·ã«
ã¢ã¯ãªã¬ãŒããšïŒéšã®ã¢ã¯ãªã«é žãä»èŸŒããšå ±
ã«ãéåéå§å€ãšããŠã®ã¢ãŸãã¹ã€ãœããããã
ãªã«ã0.15éšå«ãé ¢é žãšãã«ã25éšæ·»å ããäžæŽ»
æ§ã¬ã¹é°å²æ°äžã§çœ®æããŠ60âã«ææž©ããŠåå¿ã
éå§ãããããã«é ¢é žãšãã«ã滎äžãã€ã€60ã62
âäžã§ïŒæéåå¿ããã次ãã§75ã78âã§ïŒæé
çæããŠã275ãã€ã¹ïŒat30âïŒã®ç²åºŠãš30.7é
éïŒ ã®åºåœ¢åãæããå ±éåç©æº¶æ¶²ïŒ¡ãåŸãã
ã¢ã¯ãªã¬ãŒããšïŒéšã®ã¢ã¯ãªã«é žãä»èŸŒããšå ±
ã«ãéåéå§å€ãšããŠã®ã¢ãŸãã¹ã€ãœããããã
ãªã«ã0.15éšå«ãé ¢é žãšãã«ã25éšæ·»å ããäžæŽ»
æ§ã¬ã¹é°å²æ°äžã§çœ®æããŠ60âã«ææž©ããŠåå¿ã
éå§ãããããã«é ¢é žãšãã«ã滎äžãã€ã€60ã62
âäžã§ïŒæéåå¿ããã次ãã§75ã78âã§ïŒæé
çæããŠã275ãã€ã¹ïŒat30âïŒã®ç²åºŠãš30.7é
éïŒ ã®åºåœ¢åãæããå ±éåç©æº¶æ¶²ïŒ¡ãåŸãã
次ã«ãã®å
±éåç©æº¶æ¶²ïŒ¡ãæ
æäœãšããŠã®åã
12ÎŒïœã®ããªãšã¹ãã«ãã€ã«ã ã®çé¢ã«ä¹Ÿç¥åŸã®
åã¿ã30ÎŒïœãšãªãããã«å¡åžä¹Ÿç¥ããŠæå§æ¥ç
æ§ã®é«ååç©è³ªå±€ã圢æããåºäœãåŸãã
12ÎŒïœã®ããªãšã¹ãã«ãã€ã«ã ã®çé¢ã«ä¹Ÿç¥åŸã®
åã¿ã30ÎŒïœãšãªãããã«å¡åžä¹Ÿç¥ããŠæå§æ¥ç
æ§ã®é«ååç©è³ªå±€ã圢æããåºäœãåŸãã
äžæ¹ãïŒã€å£ãã©ã¹ã³ã«ãã€ãœã¢ãã«ã¢ã¯ãªã¬
ãŒã70éšããšããã·ãšãã«ã¢ã¯ãªã¬ãŒã10éšåã³
é ¢é žããã«20éšãããªãæ··åç©ãäžèšå ±éåç©æº¶
液ãšåæ§ã®æäœãæœããŠééãã189ãã€ãº
ïŒat30âïŒã®ç²åºŠãš30.9ééïŒ ã®åºåœ¢åãæãã
å ±éåç©æº¶æ¶²ïŒ¢ãåŸãã
ãŒã70éšããšããã·ãšãã«ã¢ã¯ãªã¬ãŒã10éšåã³
é ¢é žããã«20éšãããªãæ··åç©ãäžèšå ±éåç©æº¶
液ãšåæ§ã®æäœãæœããŠééãã189ãã€ãº
ïŒat30âïŒã®ç²åºŠãš30.9ééïŒ ã®åºåœ¢åãæãã
å ±éåç©æº¶æ¶²ïŒ¢ãåŸãã
ãã®å
±éåç©æº¶æ¶²ïŒ¢ãå¥é¢æ§ã©ã€ããŒäžã«ä¹Ÿç¥
åŸã®åã¿ã40ÎŒïœãšãªãããã«å¡åžä¹Ÿç¥ããŠãæ
å§æ§æ¥çå€èãåŸãã
åŸã®åã¿ã40ÎŒïœãšãªãããã«å¡åžä¹Ÿç¥ããŠãæ
å§æ§æ¥çå€èãåŸãã
次ã«äžèšåºäœã®é«ååç©è³ªå±€é¢ã«ãªãã«ã€ã³ç²
æ«ã540ÎŒïœ/cm2ãšãªãããã«æ£åžãããã®äžã«äž
èšæ¥çå€èã貌ãåããŠã70âã§ïŒåéå§çããŠ
è€åå»è¬è£œå€ãåŸãã
æ«ã540ÎŒïœ/cm2ãšãªãããã«æ£åžãããã®äžã«äž
èšæ¥çå€èã貌ãåããŠã70âã§ïŒåéå§çããŠ
è€åå»è¬è£œå€ãåŸãã
åŸããã補å€ã®ãªãã«ã€ã³å«æéã¯ãåæ枬å®
å€ã§535ÎŒïœ/cm2ã§ãããå®è³ªçã«è¬ç©ã®æ倱ã¯ãª
ããã®ã§ããã
å€ã§535ÎŒïœ/cm2ã§ãããå®è³ªçã«è¬ç©ã®æ倱ã¯ãª
ããã®ã§ããã
å®æœäŸ ïŒ
åã60ÎŒïœã®ããªãšãã¬ã³ãã€ã«ã ã«ãå®æœäŸ
ïŒã®å ±éåç©æº¶æ¶²ïŒ¢ã也ç¥åŸã®åã¿ã25ÎŒïœãšãª
ãããã«å¡åžä¹Ÿç¥ããŠãæå§æ¥çæ§ã®é«ååç©è³ª
å±€ã圢æããåºäœãåŸãã
ïŒã®å ±éåç©æº¶æ¶²ïŒ¢ã也ç¥åŸã®åã¿ã25ÎŒïœãšãª
ãããã«å¡åžä¹Ÿç¥ããŠãæå§æ¥çæ§ã®é«ååç©è³ª
å±€ã圢æããåºäœãåŸãã
äžæ¹ãå®æœäŸïŒã®å
±éåç©æº¶æ¶²ïŒ¡ãå¥é¢æ§ã©ã€
ããŒäžã«ä¹Ÿç¥åŸã®åã¿ã25ÎŒïœãšãªãããã«å¡åž
也ç¥ããŠãæå§æ§æ¥çå€èãåŸãã
ããŒäžã«ä¹Ÿç¥åŸã®åã¿ã25ÎŒïœãšãªãããã«å¡åž
也ç¥ããŠãæå§æ§æ¥çå€èãåŸãã
次ã«åºäœã®é«ååç©è³ªå±€é¢ã«ãïŒééïŒ
ã®ãã
ãµã¡ãµãŸã³å«æãšãã«ã¢ã«ã³ãŒã«ãããããµã¡ãµ
ãŸã³éã10ÎŒïœ/cm2ãšãªãããã«å¡åžãããã®äž
ã«äžèšã®æ¥çå€èã貌ãåãã40âã§ïŒåéå§ç
ããŠè€åå»è¬è£œå€ãåŸãã
ãµã¡ãµãŸã³å«æãšãã«ã¢ã«ã³ãŒã«ãããããµã¡ãµ
ãŸã³éã10ÎŒïœ/cm2ãšãªãããã«å¡åžãããã®äž
ã«äžèšã®æ¥çå€èã貌ãåãã40âã§ïŒåéå§ç
ããŠè€åå»è¬è£œå€ãåŸãã
åŸããã補å€ã®ãããµã¡ãµãŸã³å«æéã¯ãåæ
枬å®å€ã§11.1ÎŒïœ/cm2ã§ãã€ãã
枬å®å€ã§11.1ÎŒïœ/cm2ã§ãã€ãã
å®æœäŸ ïŒ
å®æœäŸïŒã®åºäœã®é«ååç©è³ªå±€é¢ã«ãïŒééïŒ
ã®ãããã°ãªã»ãªã³å«æéä¹³ç³ç²æ«ãããçŽ æš¹è
補ãžã©ã§120ÎŒïœ/cm2ãšãªãããã«åäžã«æ¡ããã
ã®ãããã°ãªã»ãªã³å«æéä¹³ç³ç²æ«ãããçŽ æš¹è
補ãžã©ã§120ÎŒïœ/cm2ãšãªãããã«åäžã«æ¡ããã
äžæ¹å¥é¢æ§ã©ã³ããŒäžã«å®æœäŸïŒã®å
±éåç©æº¶
液ã也ç¥åŸã®åã¿ã20ÎŒïœãšãªãããã«å¡åžä¹Ÿ
ç¥ããŠæå§æ§æ¥çå€èãåŸãã
液ã也ç¥åŸã®åã¿ã20ÎŒïœãšãªãããã«å¡åžä¹Ÿ
ç¥ããŠæå§æ§æ¥çå€èãåŸãã
次ã«è©²æ¥çå€èãåèšåºäœã®ç²æ«å±€é¢ã«è»¢ç
ãã50âã§ïŒåéå ç±å å§ãããã®åŸå®€æž©ã§24æ
éçæããŠè€åå»è¬è£œå€ãåŸãã
ãã50âã§ïŒåéå ç±å å§ãããã®åŸå®€æž©ã§24æ
éçæããŠè€åå»è¬è£œå€ãåŸãã
åŸããã補å€ã®ãããã°ãªã»ãªã³å«æéã¯ãå
æ枬å®å€ã§119ÎŒïœ/cm2ã§ãããå®è³ªçã«è¬ç©ã®æ
倱ã¯ãªããã®ã§ããã
æ枬å®å€ã§119ÎŒïœ/cm2ã§ãããå®è³ªçã«è¬ç©ã®æ
倱ã¯ãªããã®ã§ããã
å®æœå ïŒ
35éšã®ã¹ãã¬ã³âã€ãœãã¬ã³âã¹ãã¬ã³ããã
ã¯å ±éåäœãŽã ãšã15éšã®æµåãã©ãã€ã³ãšã30
éšã®èèªæç³»ç³æ²¹æš¹èãšãããªãæ··åç©ããã«ãš
ã³ã§æº¶è§£ãããããå¥é¢ã©ã€ããŒäžã«ä¹Ÿç¥åŸã®å
ã¿ã30ÎŒïœãšãªãããã«å¡åžä¹Ÿç¥ããŠæå§æ§æ¥ç
å€èãåŸãã
ã¯å ±éåäœãŽã ãšã15éšã®æµåãã©ãã€ã³ãšã30
éšã®èèªæç³»ç³æ²¹æš¹èãšãããªãæ··åç©ããã«ãš
ã³ã§æº¶è§£ãããããå¥é¢ã©ã€ããŒäžã«ä¹Ÿç¥åŸã®å
ã¿ã30ÎŒïœãšãªãããã«å¡åžä¹Ÿç¥ããŠæå§æ§æ¥ç
å€èãåŸãã
ãã®èé¢ã«ã15ééïŒ
ã®ãµãªãã«é
žã¡ãã«ãβ
âã·ã¯ãããã¹ããªã³ã§å æ¥ããŠç²æ«ããã©ã§å
äžã«æ¡ãã500ÎŒïœ/cm2ã®ãµãªãã«é žã¡ãã«éãšãª
ãããã«èšå®ããã
âã·ã¯ãããã¹ããªã³ã§å æ¥ããŠç²æ«ããã©ã§å
äžã«æ¡ãã500ÎŒïœ/cm2ã®ãµãªãã«é žã¡ãã«éãšãª
ãããã«èšå®ããã
ãã®ç²æ«å±€é¢ã«ãå®æœäŸïŒã®åºäœãé«ååç©è³ª
å±€ãä»ããŠéãåãã70âã§ïŒåéå ç±å å§ãã
ãã®åŸ24æéçæããŠè€åå»è¬è£œå€ãåŸãã
å±€ãä»ããŠéãåãã70âã§ïŒåéå ç±å å§ãã
ãã®åŸ24æéçæããŠè€åå»è¬è£œå€ãåŸãã
該補å€ã®åæ枬å®å€ã¯497ÎŒïœ/cm2ã§ãã€ãã
å®æœäŸ ïŒ
åã20ÎŒïœã®ã¬ãŒãšã³äžç¹åžãšåã40ÎŒïœã®ãš
ãã¬ã³âé ¢é žããã«å ±éåäœïŒé ¢é žããã«å«æé
28ééïŒ ïŒãã€ã«ã ãšã®ã©ãããŒããã€ã«ã ã®äž
ç¹åžé¢ã«ãäžèšã®çµæç©ãããªãé«ååç©è³ªå±€
ïŒåã70ÎŒïœïŒã圢æããäž¡é¢ãããªãšã¹ãã«ã
ã€ã«ã ïŒåã25ÎŒïœïŒã§è¢«èŠãã50âã§ïŒæéç
æããåºäœãåŸãã
ãã¬ã³âé ¢é žããã«å ±éåäœïŒé ¢é žããã«å«æé
28ééïŒ ïŒãã€ã«ã ãšã®ã©ãããŒããã€ã«ã ã®äž
ç¹åžé¢ã«ãäžèšã®çµæç©ãããªãé«ååç©è³ªå±€
ïŒåã70ÎŒïœïŒã圢æããäž¡é¢ãããªãšã¹ãã«ã
ã€ã«ã ïŒåã25ÎŒïœïŒã§è¢«èŠãã50âã§ïŒæéç
æããåºäœãåŸãã
é«ååç©è³ªïŒå¹³åéå床50000ã®ããªã¢ã¯ãªã«
é žãããªãŠã ïŒéšã82.6éšã®æ°Žã«æº¶è§£ããããã
æ¹æãã€ã€ã0.4éšã®ããªã°ãªã·ãžã«ã€ãœã¢ãã¬
ãŒãã10éšã®æ°Žã«æº¶è§£ãããã®ãæ·»å æ··åããæ¶
æ©åããªã¢ã¯ãªã«é žç³»å«æ°Žã²ã«ã
é žãããªãŠã ïŒéšã82.6éšã®æ°Žã«æº¶è§£ããããã
æ¹æãã€ã€ã0.4éšã®ããªã°ãªã·ãžã«ã€ãœã¢ãã¬
ãŒãã10éšã®æ°Žã«æº¶è§£ãããã®ãæ·»å æ··åããæ¶
æ©åããªã¢ã¯ãªã«é žç³»å«æ°Žã²ã«ã
äžæ¹ãå¹³åéå床20000ã®ããªã¢ã¯ãªã«é
žãã
ãªãŠã ïŒéšãã°ãªã»ãªã³ïŒéšã82.6éšã®æ°Žã«æº¶è§£
ãããããæ¹æãã€ã€ã0.4éšã®ããªã°ãªã·ãžã«
ã€ãœã·ã¢ãã¬ãŒãã10éšã®æ°Žã«æº¶è§£ãããã®ãæ·»
å æ··åãããããããªãšã¹ãã«ãã€ã«ã ãããªã
å¥é¢æ§ã©ã€ããŒäžã«30ÎŒïœãšãªãããã«å¡åžãã
ãã®å¡åžé¢ãããªãšã¹ãã«ãã€ã«ã ã§è¢«èŠããŠã
50âã§ïŒæéçæããŠãæ¶æ©åããªã¢ã¯ãªã«é žç³»
å«æ°Žã²ã«ãããªãæå§æ§æ¥çå€èãåŸã 次ã«åèšåºäœã®é«ååç©è³ªå±€é¢ã«ãåã15ÎŒïœ
ã®ã¬ãŒãšã³äžç¹åžã«ã€ã³ãã¡ã¿ã·ã³å«æã¯ãªãŒã
ç¶ãå«æµžå¡åžïŒã€ã³ãã¡ã¿ã·ã³é350ÎŒïœ/cm2ïŒã
ãæ äœãéãåããããã«ãã®äžã«äžèšæ¥çå€è
ãéãåããŠå§çãããããã¢ã«ãããŠã 容åšã«
ãŠå è£ ãã50âã§24æéçæããŠãè€åå»è¬è£œå€
ãåŸãã
ãªãŠã ïŒéšãã°ãªã»ãªã³ïŒéšã82.6éšã®æ°Žã«æº¶è§£
ãããããæ¹æãã€ã€ã0.4éšã®ããªã°ãªã·ãžã«
ã€ãœã·ã¢ãã¬ãŒãã10éšã®æ°Žã«æº¶è§£ãããã®ãæ·»
å æ··åãããããããªãšã¹ãã«ãã€ã«ã ãããªã
å¥é¢æ§ã©ã€ããŒäžã«30ÎŒïœãšãªãããã«å¡åžãã
ãã®å¡åžé¢ãããªãšã¹ãã«ãã€ã«ã ã§è¢«èŠããŠã
50âã§ïŒæéçæããŠãæ¶æ©åããªã¢ã¯ãªã«é žç³»
å«æ°Žã²ã«ãããªãæå§æ§æ¥çå€èãåŸã 次ã«åèšåºäœã®é«ååç©è³ªå±€é¢ã«ãåã15ÎŒïœ
ã®ã¬ãŒãšã³äžç¹åžã«ã€ã³ãã¡ã¿ã·ã³å«æã¯ãªãŒã
ç¶ãå«æµžå¡åžïŒã€ã³ãã¡ã¿ã·ã³é350ÎŒïœ/cm2ïŒã
ãæ äœãéãåããããã«ãã®äžã«äžèšæ¥çå€è
ãéãåããŠå§çãããããã¢ã«ãããŠã 容åšã«
ãŠå è£ ãã50âã§24æéçæããŠãè€åå»è¬è£œå€
ãåŸãã
該補å€ã®ã€ã³ãã¡ã¿ã·ã³å«æéã¯ãåæ枬å®å€
ã§352ÎŒïœ/cm2ã§ãã€ãã
ã§352ÎŒïœ/cm2ã§ãã€ãã
å®æœäŸ ïŒ
å®æœäŸïŒã®åºäœã®é«ååç©è³ªå±€é¢ã«ãïŒééïŒ
ã®ãã«ãªã·ããã³ã¢ã»ãããå«æãããã¬ã³ã°ãª
ã³ãŒã«ããã€ãã³äžç¹åžãããã«å«æµžå¡åžïŒãã«
ãªã·ããã³ã¢ã»ãããå«æé10.5ÎŒïœ/cm2ïŒãã
æ äœãéãåããããã«ãã®äžã«å®æœäŸïŒãçšã
ãæå§æ§æ¥çå€èãéãåããŠå§çããè€åå»è¬
補å€ãåŸãã
ã®ãã«ãªã·ããã³ã¢ã»ãããå«æãããã¬ã³ã°ãª
ã³ãŒã«ããã€ãã³äžç¹åžãããã«å«æµžå¡åžïŒãã«
ãªã·ããã³ã¢ã»ãããå«æé10.5ÎŒïœ/cm2ïŒãã
æ äœãéãåããããã«ãã®äžã«å®æœäŸïŒãçšã
ãæå§æ§æ¥çå€èãéãåããŠå§çããè€åå»è¬
補å€ãåŸãã
該粟å€ã®ãã«ãªã·ããã³ã¢ã»ãããå«æéã¯ã
åæ枬å®å€ã§10.6ÎŒïœ/cm2ã§ãã€ãã
åæ枬å®å€ã§10.6ÎŒïœ/cm2ã§ãã€ãã
å®æœäŸ ïŒ
å®æœäŸïŒã®åºäœã®é«ååç©è³ªå±€é¢ã«ãïŒééïŒ
ã®ãªãã«ã€ã³å«æ軜質æµåãã©ãã€ã³ã280ÎŒïœ/
cm2ãšãªãããã«å¹ ïŒcmãééïŒmmã®çç¶ã«å¡åž
ãããã®äžã«å®æœäŸïŒã®æå§æ§æ¥çå€èã貌ãå
ããŠ70âã§ïŒåå§çããè€åå»è¬è£œå€ãåŸãã
ã®ãªãã«ã€ã³å«æ軜質æµåãã©ãã€ã³ã280ÎŒïœ/
cm2ãšãªãããã«å¹ ïŒcmãééïŒmmã®çç¶ã«å¡åž
ãããã®äžã«å®æœäŸïŒã®æå§æ§æ¥çå€èã貌ãå
ããŠ70âã§ïŒåå§çããè€åå»è¬è£œå€ãåŸãã
該補å€ã®ãªãã«ã€ã³å«æéã¯ãåæ枬å®å€ã§
290ÎŒïœ/cm2ã§ãã€ãã
290ÎŒïœ/cm2ã§ãã€ãã
äžèšåå®æœäŸããæãããªåŠããæ¬çºæã®è£œæ³
ã«ããã°ã補é å·¥çšäžã«ãããè¬ç©ã®å解ãæ倱
ããªãäºå®ãé¡èã§ããã
ã«ããã°ã補é å·¥çšäžã«ãããè¬ç©ã®å解ãæ倱
ããªãäºå®ãé¡èã§ããã
ãŸã補å€ã«ãããŠãæå§æ§æ¥çå€èãžã®è¬ç©ã®
æ¡æ£ç§»åã¯ãè¬ç©ã®æ°Žäžãžã®æŸåºçãå³é¢ã«ç€ºã
ãåŠã極ããŠé«ãäºå®ãããæããã§ããããªã
å³é¢äžã®æ°åã¯å€«ã å®æœäŸã«å¯Ÿå¿ããŠããã
æ¡æ£ç§»åã¯ãè¬ç©ã®æ°Žäžãžã®æŸåºçãå³é¢ã«ç€ºã
ãåŠã極ããŠé«ãäºå®ãããæããã§ããããªã
å³é¢äžã®æ°åã¯å€«ã å®æœäŸã«å¯Ÿå¿ããŠããã
æ°Žäžãžã®æŸåºçã¯äžèšããæ¹æ³ã§æž¬å®ãããã®
ã§ããã
ã§ããã
ãµã³ãã«ïŒïŒÃïŒcmïŒã30âã«ä¿æãã200ml
ã®æ°Žã«æµžæŒ¬ãæ¯ãšãããæå®æéããšã«æ°ŽïŒmlã
ãµã³ããªã³ã°ããé«é液äœã¯ãããã°ã©ãã€ãŒè£
眮ã«ãã枬å®ããããŸãè¬ç©ãšããŠãããã°ãªã»
ãªã³ãçšãããã®ã«ã€ããŠã¯ãïœâãããµã³ã§æœ
åºåŸã¬ã¹ã¯ãããã°ã©ãã€ãŒè£ 眮ã§æž¬å®ããããª
ãåããåæå«æéã100ïŒ ãšããŠèšç®ããã
ã®æ°Žã«æµžæŒ¬ãæ¯ãšãããæå®æéããšã«æ°ŽïŒmlã
ãµã³ããªã³ã°ããé«é液äœã¯ãããã°ã©ãã€ãŒè£
眮ã«ãã枬å®ããããŸãè¬ç©ãšããŠãããã°ãªã»
ãªã³ãçšãããã®ã«ã€ããŠã¯ãïœâãããµã³ã§æœ
åºåŸã¬ã¹ã¯ãããã°ã©ãã€ãŒè£ 眮ã§æž¬å®ããããª
ãåããåæå«æéã100ïŒ ãšããŠèšç®ããã
å³é¢ã¯æ¬çºæã®è£œæ³ã«ãŠåŸãããè€åå»è¬è£œå€
ã®æŸåºçã瀺ãããã®ã§ããã
ã®æŸåºçã瀺ãããã®ã§ããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ å®è³ªçã«è¬ç©ãæ¡æ£ééããªãæ æäœã®è¡šé¢
ã«é«ååç©è³ªå±€ã圢æããŠãªãåºäœã®è©²å±€é¢ã«ã
è¬ç©åã¯è¬ç©ãä¿æããæ äœãéšååã¯å šé¢çã«
ä»åšãããŠè¬ç©ãæ¡æ£ç§»åãããæå§æ§æ¥çå€è
ãå§çããåèšè¬ç©ãåèšæ¥çå€èã«æ¡æ£ç§»åã
ããŠãªãè€åå»è¬è£œå€ã®è£œæ³ã ïŒ è¬ç©ãä¿æããæ äœãåžžæ ã§æ¶²ç¶ãååºåœ¢ç¶
åã¯åºåœ¢ç¶ã®çŸ€ããéžã°ããïŒçš®ã§ããæ äœææ
ã«è¬ç©ãå«æµžåã¯æ··åæ段ã«ãŠä¿æããããã®ã§
ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®è€åå»è¬è£œå€ã®
補æ³ã
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3109782A JPS58148815A (ja) | 1982-02-26 | 1982-02-26 | è€åå»è¬è£œå€ã®è£œæ³ |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3109782A JPS58148815A (ja) | 1982-02-26 | 1982-02-26 | è€åå»è¬è£œå€ã®è£œæ³ |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS58148815A JPS58148815A (ja) | 1983-09-05 |
JPS6123165B2 true JPS6123165B2 (ja) | 1986-06-04 |
Family
ID=12321891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3109782A Granted JPS58148815A (ja) | 1982-02-26 | 1982-02-26 | è€åå»è¬è£œå€ã®è£œæ³ |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS58148815A (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3629304A1 (de) * | 1986-08-28 | 1988-03-24 | Lohmann Gmbh & Co Kg | Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung |
US4915950A (en) * | 1988-02-12 | 1990-04-10 | Cygnus Research Corporation | Printed transdermal drug delivery device |
DE3843238C1 (ja) * | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
JP2697191B2 (ja) * | 1989-10-03 | 1998-01-14 | æ¥æ±é»å·¥æ ªåŒäŒç€Ÿ | çµç®åžåè£œå€ |
JP2849950B2 (ja) * | 1990-11-30 | 1999-01-27 | æ¥æ±é»å·¥æ ªåŒäŒç€Ÿ | çµç®åžåè£œå€ |
US6632872B1 (en) | 2000-09-19 | 2003-10-14 | 3M Innovative Properties Company | Adhesive compositions including self-assembling molecules, adhesives, articles, and methods |
US20060188558A1 (en) * | 2005-02-18 | 2006-08-24 | Mylan Technologies, Inc. | Transdermal systems having control delivery system |
JP5535497B2 (ja) * | 2008-03-06 | 2014-07-02 | ãªã³ããã¯æ ªåŒäŒç€Ÿ | çµç®åžå貌ä»å€ |
JP5460971B2 (ja) * | 2008-03-28 | 2014-04-02 | ãªã³ããã¯æ ªåŒäŒç€Ÿ | çµç®åžå貌ä»å€ |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS455674Y1 (ja) * | 1966-11-18 | 1970-03-18 | ||
JPS4826201A (ja) * | 1971-08-10 | 1973-04-06 | ||
JPS55160717A (en) * | 1979-06-01 | 1980-12-13 | Toyo Ink Mfg Co Ltd | Preparation of application |
-
1982
- 1982-02-26 JP JP3109782A patent/JPS58148815A/ja active Granted
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS455674Y1 (ja) * | 1966-11-18 | 1970-03-18 | ||
JPS4826201A (ja) * | 1971-08-10 | 1973-04-06 | ||
JPS55160717A (en) * | 1979-06-01 | 1980-12-13 | Toyo Ink Mfg Co Ltd | Preparation of application |
Also Published As
Publication number | Publication date |
---|---|
JPS58148815A (ja) | 1983-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI95539B (fi) | Transdermaalinen jÀrjestelmÀ, sen valmistusmenetelmÀ ja kÀyttö | |
US6893655B2 (en) | Transdermal delivery devices | |
JPS6059207B2 (ja) | è€å補å€ã®è£œæ³ | |
JPH0460091B2 (ja) | ||
JPS59181207A (ja) | çµç®è¬å€ | |
GB2105990A (en) | Adhesive skin patches | |
WO2001072282A1 (en) | Self-emulsifying matrix type transdermal preparation | |
FI102038B (fi) | AnnostelutyypiltÀÀn ihon lÀpÀisevÀn nitroglyseriinin farmaseuttisen va lmisteen valmistusmenetelmÀ | |
JPS60185713A (ja) | çµç®åžåæ§è£œå€åã³ãã®è£œæ³ | |
US5714162A (en) | Scopolamine patch | |
JPS6123165B2 (ja) | ||
US10307380B1 (en) | Composition and method for transdermal lidocaine delivery | |
KR102039762B1 (ko) | ë€ê³µì± 믞늜ìë€ì í¬íší ê²œíŒ ì¥ì¹ | |
CS264317B2 (en) | Process for preparing pharmaceutical agent | |
JPH0459296B2 (ja) | ||
JP2869167B2 (ja) | åŸæŸæ§è²Œä»è£œå€ | |
JPS6059208B2 (ja) | è€åè£œå€ | |
JPS5835113A (ja) | è€åè£œå€ | |
JPH0238569B2 (ja) | ||
JPS6038368B2 (ja) | 貌ä»å€ã®è£œé æ¹æ³ | |
JPS61221120A (ja) | å€çšå»è¬éšæ | |
JPS5919926B2 (ja) | è¬ç©æäžéšæ | |
JP3713295B2 (ja) | çµç®é©çšè£œå€åãåŸæŸæ§è¬å€æ äœãšãã®è£œé æ¹æ³ããã³çµç®é©çšè£œå€ | |
JP3098095B2 (ja) | é湿æ§æ¯æäœãçšãã貌ä»å€ | |
JPS596286B2 (ja) | ãâãè£œå€ |